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Buruli Ulcer Disease (BUD) is a severe, neglected tropical disease of the skin caused by 
the acid-fast bacillus Mycobacterium ulcerans. The disease is characterized by necrosis of 
subcutaneous adipose tissue, and healing with contracture and/or intense scarring of the skin. 
Little is known about the host response to M. ulcerans from transmission and infection, through 
the course of disease and resolution. Understanding the host-pathogen interaction is key to 
development of treatment programs for this neglected disease. In this dissertation, a systems 
biology approach was used to evaluate a laboratory mouse model of M. ulcerans infection and 
an analysis of the capability of Anopheles gambiae mosquitoes to maintain and transmit the 
bacterium is described following the introduction and literature review (Chapters 1 and 2).  
In Chapter 4, the histology and immune responses in a mouse model that mimics human 
M. ulcerans infection is described, providing insight into the host response during active 
infection with M. ulcerans. Specifically, non-toxigenic, virulent M. ulcerans was inoculated into 
the mouse footpad, and the resulting progression of infection and immune response was 
characterized in both a wild-type C57BL/6 mouse and an immunodeficient Rag1tm1Mom (Rag-/-) 
mutant mouse strain. Assessment of the bacterial burden in the mouse as a correlate of the 
infectious process was documented and demonstrated a persistent or latent feature of 
infection. Additionally, a mechanism of host immunosuppression was described in 
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immunocompetent animals, in the absence of the toxin mycolatone, highlighting the need for 
better understanding of virulence determinants employed by the bacilli during infection.   
Chapter 5 reports an expansion of the mouse model to investigate the transmission of 
M. ulcerans by a mosquito vector. After exposure to M. ulcerans, larval A. gambiae mosquitoes 
experienced significant developmental delay, resulting in reduced survival and stunted growth. 
Adult A. gambiae demonstrated bacterial contamination of their external mouthparts with live 
M. ulcerans bacteria. The contamination pattern of adult mosquitoes implicates these insects in 
the mechanical transmission of M. ulcerans. The mouse model from chapter 4 was used to 
evaluate mosquito borne transmission of the bacillus. Infected mosquitoes were allowed to 
take a blood meal from mice. The subsequent immune response of the mice was measured for 
sero-reactivity against M. ulcerans. In addition, larval mosquitoes were documented to readily 
consume water-borne M. ulcerans, consistent with their feeding mechanism. Thus, larval 
mosquitoes represent a reservoir or point of environmental maintenance of the pathogen.   
Chapter 6 details the initiation of a study to investigate the metabolic effects of the 
exposure of adult mosquitoes to virulent M. ulcerans. The developmental delay and subsequent 
stunted growth of adult mosquitoes after exposure to M. ulcerans was analyzed through the 
mass spectrometric investigation of small molecules of metabolism in an attempt to elucidate 
the biological effects of exposure. In summary (Chapter 7), the availability of a well-defined 
animal model for BUD provides a valuable tool, which can be used to investigate the specialized 
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History of Buruli Ulcer Disease 
Buruli Ulcer Disease (BUD) is a physically disfiguring and socially debilitating ulcerative 
disease of the integument caused by Mycobacterium ulcerans and is classified as a neglected 
tropical disease. Despite initial characterization of the disease in 1897 by Sir Albert Cook in 
Uganda, basic questions remain regarding the route of transmission, environmental 
maintenance, and disease pathogenesis.  In 1948, formal discovery and description of M. 
ulcerans infection defining a “new mycobacterial infection in man,” was achieved by MacCallum 
et al. (1948) to include ulceration with atypical histological and bacteriological characteristics in 
the Bairnsdale region of eastern Victoria, Australia (2). Preceding this description, and the 
tentative assignment of a mycobacterial etiology, scattered reports of mycobacteria-implicated 
ulcerations in Africa and Australia could be traced back to the second half of the nineteenth 
century. Over the following decades, hundreds of cases of BUD were reported in sub-Saharan 
Africa (3, 4), further refining the description of the disease. While a dozen names have been 
proposed to describe infection with M. ulcerans, including Bairnsdale Ulcer, the designation of 
Buruli Ulcer was coined by Clancey et al. (1962) corresponding to an endemic riverine region in 
Uganda and the location of many of the first characterized patients (5). During these early 
years, continued investigation of M. ulcerans was complicated by the inability to culture the 
bacteria. In a serendipitous breakthrough, the first successful culture was obtained using a 
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defective incubator maintaining 33°C, the temperature coinciding with M. ulcerans tropism for 
the outer layers of the skin.  
 Epidemiologic and bacteriologic investigations were continued throughout the 1970’s. 
This time was characterized by the discovery of risk factors associated with infection, namely 
standing water and insects (6, 7), and attempts to refine the case definition (8, 9). The 
development and testing of a purified protein derivative skin test reagent, termed Burulin, was 
in important breakthrough for the diagnosis of Buruli Ulcer disease (10). However, difficulties 
were arising regarding the specificity and application of the tool in endemic areas (11). 
Importantly, during this time, the only known toxin to be produced by a Mycobacterium was 
identified to be secreted by M. ulcerans and its effects evaluated in a guinea pig model (12). It 
would not be until 25 years later, with the assistance of Delphi Chatterjee from Colorado State 
University, that the toxin would be identified as a small, lipid-like polyketide implicated in a 
variety of potent cytotoxic and immunomodulatory effects associated with infection (13). 
Research in the 21st century has uncovered a vast amount of information regarding M. ulcerans 
infection. The first successful culture from an environmental location provided great insight into 
the mechanisms of bacterial persistence outside the host and the environmental niche of the 
pathogen (14). In 2004, the World Health Assembly passed a resolution calling for advanced 
research into the disease.  Shortly thereafter, multiple research consortia were formed to 
streamline the efforts of collaboration for the development of prevention and control 
strategies. The standardization and acceptance of criteria for staging and guidance for 
healthcare workers greatly improved the long-term prognosis of Buruli Ulcer disease (15). 
Recent advances in Buruli Ulcer disease research have led to the development of new 
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diagnostic approaches using mass spectrometry (16), a developing understanding of the host 
immune response (17), and continued studies investigating the potential vector capacity of 
insects in the transmission of the bacteria (18). The current state of research into this emerging 
pathogen is fraught with many challenges, further compounded by its place at the bottom of 
the research funding scale compared to other neglected tropical diseases (19).  
Taxonomy, Phylogeny, and Genetics 
Mycobacteria are a diverse and ubiquitous genus of microorganisms, encompassing 
species of pathogenic and non-pathogenic bacteria (Figure 1).  The genus Mycobacteria 
contains the infamous pathogens M. tuberculosis and M. leprae, in addition to members of the 
Figure 1: Phylogeny of Mycobacterium genus. Lineages are denoted based on growth rate of organisms. 




Mycobacterium avium complex (MAC) and a wide array of newly designated non-tuberculous 
mycobacteria (NTM) of significant public health concern. The evolution of M. ulcerans is 
primarily associated with the genetic divergence from a common ancestor shared by 
Mycobacterium marinum and the acquisition of a large circular plasmid (pMUM001) encoding 
the polyketide toxin, mycolactone (20). This divergence occurred approximately one million 
years ago and describes the evolutionary diversion from a human and fish pathogen into a 
devastating infection of the skin and underlying tissue in humans (Figure 2). Despite the 
contrasting phenotypes of M. marinum and M. ulcerans, the pair share nearly identical genome 
sequences (98.3% homology), compared to a 78.5% identity to M. tuberculosis (21, 22). The 
complete genome sequence of M. ulcerans consists of a circular chromosome of 5632 Kb and a 
virulence plasmid of 174 Kb, interspersed by 771 pseudogenes and 304 insertion sequence 
elements. Through lateral gene transfer and reductive evolution, the M. ulcerans genome has 
lost approximately 1000kb of DNA compared to its M. marinum progenitor, split between 
twelve regions of between 2 and 53 kb in size (23). Multilocus sequence analysis (MLSA) 
revealed clear delineation between M. marinum and M. ulcerans, also describing clonality 
Figure 2: Splits chart of the phylogenetic relationship among M. ulcerans (MU) and M. marinum (MM) 
genotypes. Edges have greater than 80% bootstrap support. Asterisk denotes edges with greater than 60% 
bootstrap support. Adapted from Stinear et al.  J. Bact. 2000 182:22. 
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among genotypes from different geographic locations (23, 24).  It is suggested this genetic 
speciation is in response to environmental changes and mammalian host adaptation, and 
perhaps indicates a passage through an evolutionary bottleneck (21). The evolution from the 
generalist M. marinum to a specialist, niche-adapted pathogen is characterized by gene loss 
due to DNA deletions and rearrangements mediated by some of the 213 copies of IS2404 and 
91 copies of IS2606 insertion sequence elements, disrupting over 110 genes (22). Such 
disruptions involving cell wall biosynthesis, carbon and amino acid metabolism, and the 
reduced transcription levels thereof help to explain, in part, the slow growth of M. ulcerans 
compared to its progenitor (22), in addition to the contribution of reduced genetic redundancy. 
The insertion sequence elements account for nearly 475 kb of DNA distributed throughout the 
genome. Most notable of these are 79 kb of sequence variation specifically among the PE/PPE 
genes encoding Gly-Ala rich cell envelope proteins, comprising 45% of the 157 regions of 
difference between M. ulcerans and M. marinum.  M. ulcerans has low variability in house-
keeping genes and other genetic elements within isolates from the same geographic region. 
However, the genomic sequences of geographic isolates can be differentiated by single 
nucleotide polymorphisims (SNP) and variable number tandem repeats (VNTR) throughout the 
genomes. Ghanaian strains, for example, contain approximately 100 SNPs compared to the 
reference strain AGY99, whereas Japanese strains can contain as many as 26,000 SNPs. VNTR 
analysis identified 9 VNTR loci as useful molecular targets to study the relationships among 
isolates (25). The combined use of multiple sequence differentiation tools (MLSA, VNTR, IS-PCR, 
SNP), the location differences of the insertion sequence elements IS2404/IS2606, and 




Figure 3: Categorical dendrogram displaying the clustering of genotypes of both M. ulcerans (MU) and M. 
marinum (MM) isolates from different geographic origins. Adapted from Stragier et al. J. Bact. 2005. 187:5. 
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isolates from West and Central Africa, including historical isolates, belong to the same genotype 
(24, 26-28), and display marked spatiotemporal homogeneity (29).   
Epidemiology and Transmission 
Buruli Ulcer disease is the third most common mycobacterial infection in immuno-
competent people following tuberculosis and leprosy (30, 31). In fact, BUD has replaced 
tuberculosis and leprosy as the most prevalent mycobacterial disease in BUD endemic 
communities, affecting up to 22% of the population within affected communities (32). 
Additionally, over the past decade, there has been a noted increase in BUD in several West 
African countries (33-35). Buruli Ulcer disease has been reported in more than 30 countries, but 
the most significant burden of disease remains in sub-Saharan Africa, and particularly the Gulf 
of Guinea region (30, 36-38). Australia has a long history with M. ulcerans and manages active 
foci of infection in the southeastern coastal regions, specifically coastal Victoria, Far North 
Queensland, Bairnsdale and Point Lonsdale (39-47).  Recently, successful cultures from 
environmental samples have demonstrated the appearance of M. ulcerans in aquatic 
environments, though environmental subsistence and the precise source of infection for 
humans remain unknown (14, 48). The route of infection is also unknown. The organism is 
postulated to enter at sites of trauma to the skin (49, 50), following contact with contaminated 
water or vegetation (51). Insects of the Hemiptera and Diptera orders are implicated in the 
transmission of Buruli Ulcer in many geographic regions, specifically the aquatic biting insects 
from the families Belostomatidae and Naucoridae (52, 53), in addition to multiple genera of 
mosquitoes (54). Indeed, an association between M. ulcerans and these insects has been well 
described, although an understanding of the true dynamics of transmission and interaction via 
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insect systems in a natural setting remains undefined.  A multitude of studies have investigated 
the association between these insects and M. ulcerans (53, 55-62). Epidemiological studies have 
described a higher rate of M. ulcerans DNA contamination of captured mosquitoes during an 
outbreak of disease compared to a non-outbreak period of time (63). Additionally, the biting 
water bugs were shown to actively transmit the pathogen to mice in the laboratory via 
contaminated raptorial arms and salivary glands (58).  Taken together, these studies describe a 
close association between the pathogen and insects, and while it is possible that their role in 
the disease lifecycle may be limited to environmental maintenance of the bacterium and not 
directly transmission, they represent a ubiquitous reservoir.  No confirmatory evidence for 
human-to-human transmission exists (64), although prolonged contact or via bite wound has 
been suggested to lead to ulceration (65, 66). 
The primary risk factors associated with transmission of Buruli Ulcer disease include a 
close association with stagnant or standing water, a lack of protective clothing, such as long 
pants and shoes, and biting aquatic insects. Unfortunately, these risk factors fail to explain the 
true dynamics associated with the emergence and development of disease. The complex 
political and socio-economic interactions in endemic areas must be accounted for to develop a 
clear understanding of the epidemiology of disease. An analysis of the socio-political climate of 
the endemic region along the Nyong River in Cameroon provided novel insights into 
mechanisms of disease transmission and susceptibility of humans (67). Deforestation and 
ecological disruptions leading to a transformation of the human interactivity within an 
ecosystem are a crucial factor in the emergence of Buruli Ulcer. Indeed, these ecological 
disruptions have been documented to be associated with disease outbreaks (68, 69). A multi-
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disciplinary approach to investigating the epidemiology of disease will lead to a better 
understanding of the infection dynamics. As an example from a historical perspective, the 
endemic Akonolinga district in Cameroon has undergone significant socio-economic upheaval in 
the last century. The transition from sustainable agriculture to large-scale commercial farming 
operations has resulted in wide-spread deforestation and disruption of the aquatic ecosystem 
(67). The general health of the population in this region has been negatively impacted by the 
reduced diversity of food and reduced community interaction. A well-documented and poorly 
understood feature of Buruli Ulcer disease are the disproportionate rates of infection in young 
children. Correlating this epidemiological finding to the generalized risk factor of environmental 
disruption, it may be surmised that the reduced food diversity has a greater impact on the 
general health and immunological development of children, thereby increasing their 
susceptibility to infection. This interaction could be used as an alternative model to predict 
emergence of the disease in other geographic locations (70). While the social sciences are often 
marginalized by biological researchers, the “One Health” perspective on the surveillance and 
research of emerging diseases will expand our understanding of the true cause and effect 
relationships that underlie the emergence and transmission of Buruli Ulcer disease (71).  
Disease Manifestations  
The pathogenesis of M. ulcerans infection is believed to follow an initial inoculation of 
the dermis, however the mechanisms behind this process are deeply hypothetical. The bacilli 
then replicate in the subcutaneous tissue resulting in necrosis (72-76). 
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After exposure and an undefined incubation period, the disease is observed to begin as a 
nodule, papule, plaque, or localized edema at or near the site of exposure (Figure 4).  
Unmanaged cases can 
progress to large ulcerative 
lesions which if left 
untreated, result in 
debilitating complications 
from scarring with 
contracture or loss of limbs or vital organs (31, 49, 77). The time to development of an 
ulceration from a nodule or other early disease state is suspected to be weeks to months, 
although the true incubation period has not been characterized to include diverse geographic 
locations and strain phenotypes (78). In an Australian cohort of Buruli Ulcer patients, the 
incubation period for the disease was described to range between 34 and 204 days, with the 
average incubation period being 135 days post exposure (79). Exposure in this study was 
described as a documented visit to an endemic region. However, these results may not be 
generalizable to other endemic regions and infection with other geographic isolates.  
Diagnosis and Treatment 
Diagnosis of M. ulcerans infection is based on clinical appearance using the World 
Health Organization case definition and common molecular techniques (34, 77, 80). 
Misclassification is a problem in both pre-ulcerative and ulcerative stages of disease due to the 
high abundance of both infectious diseases (cutaneous leishmaniasis) and cancer (squamous 
cell carcinoma) with a similar presentation.  Case confirmation requires two positive tests out of 
Figure 4: Plaque formation (left) and ulceration (right) characteristic of 




the following: Ziehl-Neelsen Acid Fast Bacilli (ZN-AFB) staining, culture, polymerase chain 
reaction (PCR), or histopathology (31, 34, 77, 81-83), but if confirmation occurs at all, it is well 
after initial clinical diagnosis and provides limited information for clinical management 
decisions. Additionally, the three later methods are not likely to be adaptable to rural, resource 
poor areas. Treatment options for BUD are limited, but management strategies continue to 
improve. Based on recent research, randomized trials, and increasing clinical experience, a 
consensus document was prepared to standardize the approach to case management in 2007 
(84). Historically, aggressive surgical excision of nodules and lesions followed by skin graft was 
the treatment of choice based upon the prevailing view that antibiotics were ineffective. Recent 
studies using antimycobacterial drug therapy, specifically rifampin-based regimens, have shown 
efficacy if utilized during early stages of disease (33, 85-88), though disease presentation during 
infection, geographic limitations, and variable incubation times influence the options for 
treatment as the disease progresses. Prospective studies in humans and model animals have 
now shown that treatment with antibiotics alone will lead to healing without recurrence (88-
90). The consensus treatment program includes daily rifampin for 8 weeks in conjunction with 
streptomycin or clarithromycin for a further 4-8 weeks (91). Currently, surgery is infrequently 
recommended as a primary intervention, although there is still a significant role for surgery in 
the initial management of severe cases or when antibiotics are contraindicated (92). 
Debridement of necrotic tissue with the goal of improving the rate of wound closure is 
indicated by the presence of bacilli during histological examination of lesion margins post 
antibiotic treatment, or when the lesion has been present for greater than 75 days (93).  
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Nearly 20% of patients experience a paradoxical reaction to antibiotic therapy, and this 
phenomenon has also been described in animal models of treatment (94-96). It is believed that 
the antibiotic therapy causes a reversal of the immunosuppression described during active 
Buruli Ulcer disease, resulting in an intense immunological reaction to persisting bacteria and 
the occasional development of new ulceration (97).  This immunosuppression is primarily 
ascribed to action of the toxin Mycolactone. However, the potency of rifampin against M. 
ulcerans infections indicates the contribution of a protein or peptide-based virulence factor 
involved in immunosuppression or persistence.  Interestingly, some anecdotal reports of a 
naturopathic approach to disease management have had some success. Application of sterile, 
high mineral-content clay to the lesions resulting in a hypoxic environment and the use of high 
temperature wraps (as indicated by the bacterium’s preferred growth temperature of 32°C) are 
viable options when antibiotic or surgical intervention would not be well-tolerated (98, 99). The 
further characterization of animal models of M. ulcerans infection in concert with increased 
awareness and reporting of the disease have significantly reduced the morbidity associated 
with Buruli Ulcer disease over the past decade.  
Physiology and virulence factors of M. ulcerans 
Generally, non-tuberculous mycobacteria (NTM) represent a diverse group of 
opportunistic pathogens capable of producing multifarious infectious phenotypes. Infections of 
lungs, skin, soft tissue, joints and bones as a consequence of NTM infection results in an 
annualized prevalence range between 7.2 and 35 cases per 100,000 persons in the North 
America alone (100, 101). It is assumed that the prevalence and incidence of NTM infection is 
significantly higher in disadvantaged areas where disease reporting and surveillance are lacking. 
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Members of the NTM classification cause a wide degree of infections, and while genotypic and 
phenotypic differences occur between species, many common mycobacterial traits are 
responsible for the potency of these infections. The physiology of mycobacteria during infection 
has been thoroughly researched over the last century, describing a wide array of virulence 
factors implicated in the survival of the bacilli, its resistance to therapeutics, and the 
persistence associated with many infections.  
Mycobacteria, in general, have evolved diverse strategies to survive within and without 
the human host. Established mycobacterial virulence factors include the prevention of the 
acidification of phagocytic vesicles (102), prevention of phagosome-lysosome fusion (103), 
resistance to antimicrobial components of the serum (104), modulation of cytokine secretion 
(105), the ability to replicate intracellularly (106, 107), and various genetic mutations promoting 
antibiotic resistance (108). In common with other bacterial pathogens adapting to new or more 
stable environments such as M. leprae and Yersinia pestis, genetic perturbations have been 
documented in the genome of M. ulcerans, including the accumulation of insertion sequence 
elements and pseudogenes, genome downsizing, and the acquisition of foreign genetic material 
conferring a selective advantage (22). As a result of reductive evolution and pseudogene 
formation, strains of M. ulcerans have lost many genes encoding some common mycobacterial 
virulence factors, in addition to resultant alterations in physiological processes and metabolism. 
While the M. ulcerans cell envelope and associated metabolites have been less well studied 
than other mycobacteria, inferences from the genome sequence can provide clues to the 
metabolic activity in regards to potential virulence determinants of M. ulcerans, namely 
components of carbon and lipid metabolism. However, little is known about metabolic 
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strategies employed by M. ulcerans during survival in any one of the several distinct niches 
thought to be occupied by the bacilli. Indeed, M. ulcerans employs profoundly different survival 
mechanisms within the host compared to other mycobacterial pathogens.  If M. ulcerans 
successfully occupies a distinct insect associated niche, as has been implicated, the synthesis of 
predicted chitinases/transglycosidases may be of significance (Burulist: MUL_0371, MUL_2210, 
MUL_2681) (109). These enzymes may provide a mechanism of attachment to or degradation 
of the N-acetyl-glucosamine polymers that comprise the major component of insect 
exoskeletons, thereby promoting colonization of insect tissues.  
A noteworthy deletion in the M. ulcerans genome includes reduction of ESX loci from 
five in M. marinum to only three in M. ulcerans and the loss of associated effector proteins 
from 18 to 2, respectively (22). The disruption of genes encoding immunodominant proteins 
involved in this system, such as ESAT-6, CFP-10, and hspX, may represent selection pressure-
induced changes resulting in immune evasion mechanisms. In other mycobacterial species, the 
esx1 locus encodes protein secretion machinery (Type VII) involved in intracellular spread and 
immunogenicity (110). Additionally, loss of this system may contribute, in part, to the reduced 
phagocytic uptake and extra-cellular persistence common to M. ulcerans infection.   
Lipid-based molecules are significant antigenic components of the mycobacterial cell 
wall that are also involved in virulence (111). The loss of many of these components in M. 
ulcerans can be explained by the reduction of polyketide synthase (PKS) genes from 27 in M. 
marinum to 12 in M. ulcerans. The contraction of lipid synthesis machinery coincides with a 
reduction of the MmpL family of lipid and polyketide transporters from 25 in M. marinum to six 
in M. ulcerans. Of the 12 remaining PKS genes, 10 are utilized in the production of important 
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cell-wall-associated lipids including mycolic acids, phthiodiolones, phenol phthiodiolones, 
mannosyl-phospholipids, and mycobactins (112, 113).  
As an example, phenolic glycolipids (PGL) are an abundant component of the cell wall of 
most mycobacteria and, as major virulence factors, are involved in host-immune modulation 
(114). M. ulcerans bacilli are able to synthesize the phenolphthiodolone lipid intermediate, 
although they lack the necessary machinery to add the rhamnosyl moiety and complete the PGL 
molecule (115). Additionally, neither M. ulcerans nor M. marinum contain an analogous PKS 
locus for the synthesis of sulfolipids (22).   
  Despite the inability to synthesize many prominent lipid species, M. ulcerans retains a 
full complement of the fatty acid synthase I/II machinery (FAS I/II) (22), and many other lipid-
associated enzymes. The conservation of anabolic lipid mechanisms highlights the importance 
of particular lipids in the physiology of M. ulcerans. Conversely, the degradation or utilization of 
host-derived lipids is also implicated as a virulence factor of M. ulcerans (116). The catabolic 
phospholipase enzymes have already been identified as virulence factors in other species of 
mycobacteria (117). The phospholipase enzymes hydrolyze phospholipids into distinct subunits 
depending on the enzyme subtype. Subsequently, products of this enzyme-catalyzed 
degradation are involved in downstream signaling events within the host (118), and are 
characterized to play a role in pathogenesis of M. tuberculosis infections (119). However, while 
the phospholipase C and D enzymes are actively synthesized and secreted during growth of M.  
ulcerans, their role during infection with M. ulcerans remains uncharacterized. The functional 
disruption or loss of some of the major immunodominant components important to other 
16 
 
mycobacterial infections may confer a selective advantage to this emerging pathogen. A 
summary of these components is included in the table below: 
 The secretion of an extra-cellular matrix (ECM) and the formation of a biofilm is another 
striking feature of M. ulcerans that is likely involved in virulence. The formation of a biofilm 
confers an advantage for many pathogenic bacteria, especially those of environmental origin 
(120). Biofilms of other human pathogens, such as Pseudomonas aeruginosa and Haemophilus 
influenzae have been well characterized and early evidence from M. ulcerans suggests biofilm 
formation may also be implicated in pathogenesis and the colonization of environmental and 
insect niches (121). The structure of the biofilm generated by M. ulcerans differs from classic 
biofilms, appearing as a thick covering of the outmost layer of cells (122). This finding contrasts 
with biofilms generated in other pathogenic bacterial species, which usually demonstrate a 
Table 1: Comparison of virulence factors between M. ulcerans and M. marinum based on 
genetic sequence are summarized (adapted from Demangel et al. Nat Rev Micro, 2009). 
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matrix of ECM and distributed bacterial cells (123). Lipids and lipoglycan components of the 
mycobacterial cell envelope such as lipoarabinomannan and PIM have also been described as 
components of M. ulcerans ECM, in addition to a significant contribution of glucose 
polysaccharides and a large variety of chaperone proteins (DnaK, GroEL, GroES) (122).     
The prolific biofilm and ECM produced by M. ulcerans has a diverse functional role, in 
both environmental persistence and pathogenesis. Aquatic plants are known to secrete organic 
compounds which can be used as a substrate for bacterial growth (124). A recent in vitro study 
by Marsollier et al. (2004) described the role aquatic plant extracts have in the promotion of 
biofilm formation of M. ulcerans (121). This study demonstrated a significant decrease in 
doubling-time (from 80 to 40 days in the study) upon exposure to crude organic plant extracts, 
suggesting M. ulcerans gains a distinct advantage by associating with and utilizing compounds 
synthesized by aquatic plants .  
 During pathogenesis of M. ulcerans infections, the ECM is involved in resistance to 
antibiotics, immune evasion, and increased cytotoxic effects (122). This finding coincides with 
other biofilm forming bacteria (125, 126). However, the impact and abundance of the M. 
ulcerans exotoxin and other uncharacterized virulence factors must also be accounted for when 
assigning the pathological contributions of the ECM.    
Toxin synthesis 
Long regarded as the primary virulence factor for M. ulcerans, the exotoxin mycolactone 
has been shown to be responsible for, in part, the dramatic cytotoxic and immunomodulatory 
effects described during infection. Acquisition of the large pMUM001 virulence plasmid 
encoding the toxin is the primary distinguishing factor associated with divergence from the M. 
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marinum common ancestor. As the only species which actively produces a toxin, M. ulcerans is 
unique within the Mycobacterium genus, and the cytopathologic effects tentatively attributed 
to the toxin underlie the case definition of Buruli Ulcer disease. The existence of a secreted 
factor involved in virulence was postulated as early as 1965 (127), although it would not be 
until 1999 that the toxin would be purified and formally described as the first macrolide 
synthesized by a bacterial pathogen (13). Structurally similar compounds have previously been 
characterized to include antibiotics (erythromycin), an immunosuppressant (rapamycin), 
antifungal agents (amphotericin B), among others, although the host derived target of action of 
these compounds can differ (128). Macrolides are complex polyketides produced as secondary 
metabolites of many soil bacteria of the order Actinomycetales and have a wide array of 
functional effects. Indeed, mycolactone is suggested to contribute to the development of 
pathologic features of Buruli Ulcer disease, although the specific role of the toxin in the 
pathogenesis of disease remains under intense investigation.  
 Structurally, the mycolactone toxin is comprised of a 12-membered ring with two 
attached unsaturated fatty-acid side chains, encoded by the extrachromosomal pMUM 
virulence plasmid. Different geographical isolates produce different structural variants of 
mycolactone, identified as mycolactone A-G (Figure 5). Structural variants are identified by the 
number and location of hydroxyl groups and double bonds, and the length of the lower 
polyunsaturated acyl side chain, while the structure and arrangement of the upper side chain 




A number of in vitro and in vivo studies in human-drived cell lines and animal models, 
have documented a wide array of mycolactone-mediated effects. In a model system developed 
by Hall et al. (Plos Pathogens 2014), a unifying mechanism of the effects exerted by 
mycolactone was proposed to describe broad spectrum inhibition of protein translocation to 
the endoplasmic reticulum (129), as opposed to inhibition of translational processes previously 
proposed (21, 130) .  While the specific molecular consequences of this action are still under 
investigation, a diverse set of immune proteins were found to be sensitive to mycolactone 
(BCA, MIP-2, G-CSF, GM-CSF, IL-27, C5/5a, IL-1RA), depending on the cell type stimulated and 
Figure 5: Mycolactone congeners of the five naturally occurring structures (A/B-F) and one unnatural structure 
(G). Adapted from Hong et al. Nat. Prod. Rep. 2008.  
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the route of stimulation. Other in vitro studies have shown numerous cell types to be sensitive 
to mycolactone (73), resulting in immunomodulation and decreasing the efficiency of the 
immune response (107). The toxin is also purported to be involved in the painlessness of the 
lesions (131).  Regulation of the toxin in vivo has not been investigated, although mechanisms 
attributed to toxin regulation have been discovered in vitro (132, 133). Overproduction of the 
mycobacterial siderophore, mycobactin, is correlated with a down-regulation of mycolactone. 
In addition, the supplementation or removal of specific carbohydrates in growth media has 
been shown to affect regulation of mycolactone synthesis. This evidence suggests that 
environmental signals may influence regulation of the toxin in different niches and pathologic 
conditions (132).   
Host-Pathogen Interactions  
Pathogenesis 
Infection with M. ulcerans is unique among other common mycobacterial infections 
with regard to the tissue tropism, lifestyle, and phenotype of the host immune response. Unlike 
other common mycobacterial infections, which tend to persist in an intracellular environment, 
Buruli Ulcer lesions predominantly contain extracellular bacilli often exclusively in the 
cutaneous, subcutaneous, and adipose tissues (72). Lesions can occur on any part of the body, 
though they tend to occur on limbs or extremities, and absent secondary infection, are painless. 
Histologic assessment demonstrates extensive coagulative necrosis with a proportionally low 
acute inflammatory response as the hallmark criteria of Buruli Ulcer disease, although there is 
considerable variation in the severity and presentation of the disease among geographic areas. 
Some investigators have considered subcategorizing M. ulcerans strains into eco-varieties or 
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ecovars to better explain the presentation diversity that can occur (134). To date, investigation 
into the mechanisms behind this pathogenesis have focused on the contribution of the toxin 
mycolactone. However, it is not clear how mycolactone contributes to the cytotoxicity or 
immunosuppression during clinical infection, as the extent of tissue degeneration and 
cytotoxicity exceeds that which would be attributable to mycolactone alone (73). It is important 
to consider that infection with non-toxigenic M. marinum, M. haemophilum, and M. 
tuberculosis can result in necrosis and cytotoxicity via other mechanisms (49, 135).   
 The pathogenesis of M. ulcerans infections is categorized based on clinical appearance 
of the lesions into a preulcerative stage (represented by a nodule, plaque, or local edema), 
ulcerative stage, and healed stage (80). After initial exposure, the bacilli survive and multiply 
during a transient, intracellular phase within the host. Initial colonization of neutrophils occurs 
during the early stages of infection (2-48 hours) and promotes persistence of the bacteria in the 
tissue (73). Through a cytotoxic mechanism, the bacilli are released from their phagocytic 
incubators and begin an extracellular lifestyle, resulting in the transition to the preulcerative 
presentation. Histologically, this stage is characterized by abundant extracellular bacilli and 
massive inflammatory cell infiltration.  Over a period of weeks to months, expanding necrosis of 
the subcutaneous and adipose tissues results in sloughing of the outer layers of skin leading to 
ulceration. Histologically, ulcerative disease is characterized by discrete foci representing 
extended acellular necrotic areas containing “clumps” or microcolonies of extracellular bacilli, 
elastolysis, and necrosis of recruited immune cells.  An important consideration during this time 
is the abundant collagen degradation, fibrosis and vasculopathy that impairs immune cell 
migration to the lesion. This pathogenesis also limits the permeation of antimycobacterial 
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treatments to locations containing susceptible bacilli. As necrosis of the subcutaneous tissues 
progresses, the ulcer becomes undermined and can spread beneath healthy epidermis. 
Spontaneous healing has been documented in some cases. The mechanism behind this 
phenomenon is unknown, and unmanaged healing can result in intense fibrosis and disfiguring 
scar formation.   
Innate Immunity 
The skin represents a physical and innate barrier against infection. Within the skin, 
specialized cells (eg. keratinocytes, Langerhans cells, tissue-resident macrophages) recognize 
and initiate immune responses to mycobacteria. This response is coordinated via signaling 
through pattern recognition receptors (PRR). Among the PRRs, the toll-like receptors (TLR) 
critical for recognition of mycobacterial pathogens are TLR2, TLR4, and TLR9 (136). A recent 
study by Peduzzi et al (2007) described the presence and activation of both plasmacytoid and 
myeloid dendritic cells during early lesion formation (137). A finding consistent with other 
dermatological conditions (138). Initial innate cell recognition of the pathogen leads to a 
proinflammatory signaling cascade, characterized by high levels of IL-6, IL-8, IFN-ɣ, and TNF-α.  
Adaptive and Humoral Immunity 
The immune response to M. ulcerans infection can be correlated to the location of the 
bacteria during infection. Early infection response is characterized by the intracellular 
localization of infecting bacilli. The initial induction of a cell-mediated immune response is a 
reaction to this intracellular infection. As infection progresses, and bacilli become 
predominantly extracellular, the cell mediated response is no longer effective. This correlates 
with the transition to a response characteristic of an extracellular infection, and the down-
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regulation of a proinflammatory, cell-mediated response. The pathogenic mechanisms of M. 
ulcerans result in an inefficient and often transitory cell-mediated response, even though 
effector mechanisms of this response are associated with protection.  
The initial immune response to Infection with M. ulcerans in humans begins with the 
induction of a local, neutrophilic inflammatory response in conjunction with the signaling of 
cell-mediated immunity involving cytokines such as TNF-α, IFN-ɣ, IL-1, IL-2, IL-12 and IL-15 (139) 
that are characteristic of a Th1 immune response. Indeed it has been suggested that a Th1 
immune response is protective and may prevent the development of disease in people exposed 
to M. ulcerans, while a Th2 response does not (140). However, the cellular response during 
ulcerative infection is minimal, due to virulence-mediated immunosuppression, resulting in the 
down regulation of the protective IFN-ɣ cytokine, in particular. Other studies have reported the 
discovery of idiopathic T-cell anergy (140, 141) and variable cytokine profiles throughout the 
lesion and over time (139, 142, 143). This suggests that at some point during infection, an 
unknown mechanism results in suppression of CMI, facilitating proliferation of bacilli and, 
inappropriately, a transition to the generation of a non-protective Th2 type response. 
Concordantly, others have demonstrated that expression of cytokines such as IL-10 and IFN-ɣ 
and activation of dendritic cells (a key cell for the induction of adaptive immunity) can vary 
considerably within ulcerative lesions (137), and throughout infection. Subsequently, a 
transition to a Th2 type response associated with lymphocyte apoptosis, necrosis, and fibrosis 
at the infectious foci including a significant decrease in protective cytokines. The mechanisms 
behind the transition to a non-protective response resulting in expansion of the lesion is 
uncharacterized but a correlation between the gradation of immune responses in leprosy and 
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Buruli Ulcer has been suggested (144). This non-protective response is associated with a 
reoccurrence of disease or the maintenance of persistent bacteria resulting in a chronic state of 
infection.  
The antibody response during M. ulcerans infection has been evaluated in the context of 
surveillance and diagnostics for many years (82, 145-147). M. ulcerans specific antigens elicit a 
steady antibody response during infection (148), and this response has been developed for use 
as a screen for exposure to the pathogen (149). Unfortunately, cross reactivity among 
environmental mycobacteria as well as possible previous exposure to M. ulcerans limits the 
application of this assay (148), as many other mycobacteria share immunogenic antigens (150). 
From an immunological perspective, the production of specific antibodies against M. ulcerans 
and their role in the development of immunity has two important aspects. First, the presence of 
specific antibody near the time of infection is associated with a beneficial effect (151), as pre-
ulcerative nodules frequently contain extracellular bacilli (49). Secondly, how antibody-
mediated immunity (AMI) and the downstream signaling of Fc receptors (FcR) (152, 153), 
polymeric Immunoglobulin G (IgG) receptors (154), and parenteral immunoglobulin (155, 156), 
interact with CMI to mount an effective immune response. The interaction between antibodies, 
FcR, and subsequent FcR signaling, may represent a novel aspect of immunogenesis during M. 











History and Distribution 
Mosquito-borne pathogens are responsible for significant morbidity and mortality on a 
global scale. The Anopheles gambiae complex (A. arabiensis, A. bwambae, A. merus, A. melas, 
A. quadriannulatus, and A. gambiae sensu stricto) plays a central role in the transmission of 
many diseases, due to diverse habitats and geographical distribution of the insects. Before 
1962, A. gambiae mosquitoes were considered a single species. By 1964, six distinct species had 
been described (identified above), categorized by differences in larval habitat and adult female 
resting and feeding behaviors. While the various A. gambiae species differ in their capacity to 
transmit pathogens, the anthropophilic nature of A. gambiae sensu stricto describes a long 
history of an intimate association between humans and the mosquito. A. gambiae is generally 
described as an afro-tropical mosquito, with the majority of the population distribution 
occuring in sub-Saharan Africa (Figure 6). However, 10 species of the Anopheles gambiae sensu 
Figure 6: The geographical distribution of Anopheles spp. (left) and endemic areas of Buruli Ulcer 
disease (right), showing significant overlap. Adapted from CDC.gov and Bulletin of the World Health 
Organization vol.83 n.10. (2005). 
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lato complex have been identified in Australia. These species show similar variability in terms of 
host-seeking behavior and vector competence described in the African complex of mosquitoes. 
Mosquitoes from multiple genera have been implicated to be involved with the environmental 
persistence of M. ulcerans in multiple geographic locations. While no definitive proof exists 
describing active transmission of M. ulcerans by mosquitoes, there is a growing body of 
evidence suggesting a role for mosquitoes in the maintenance of the bacilli in the environment. 
Best known for the transmission of malaria, lymphatic filariasis, and numerous viral 
infections, the Anopheline mosquitoes have been implicated as disease vectors for millennia. 
The effects of ongoing climate change are predicted to result in expansion of suitable 
environments for Anopheline development (157), which will have a significant impact on the 
incidence of many mosquito-borne pathogens. The hematophagous nature of the mosquito 
provides the insects with a protein source for egg development but also results in exposure to 
pathogens and, subsequently, the potential to transmit those microbes to susceptible 
organisms.      
Development in aquatic environments 
Early development of mosquitoes occurs in an aquatic environment and the subsequent 
lifecycle of the insects is dependent on a close association with water. Larval mosquitoes are 
commonly found in habitats endemic for Buruli Ulcer disease (158). Development of larval 
mosquitoes occurs primarily at the air-water interface near plant stems and algal mats, where 
the larvae feed using labral head fans to filter microbes and organic matter from the water 
column (159, 160). The idea that larval mosquitoes may serve as bioaccumulators or 
concentrators of environmental M. ulcerans, thereby initiating the passage of M. ulcerans 
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through an aquatic food web has been explored (62, 161).  Thus, it is accepted that larval 
mosquitoes will readily consume M. ulcerans and promote the maintenance of the bacilli in the 
environment.  
Mechanical transmission and Vector Capacity 
Risk factors for the development of Buruli Ulcer disease, including an association with 
standing water and the protective effect of bed nets described previously, implicate an insect in 
the transmission of the disease. Indeed, much of the sympatry existing between A. gambiae 
and M. ulcerans is a result of many common themes regarding the geographic and 
environmental location of the two organisms, which is a requirement for assignment of 
mosquitoes as a vector.  Together with mosquitoes, other insects have been implicated in 
transmission of M. ulcerans and have received considerable attention, specifically members of 
the Naucoridae and Belostomatidae genra (52, 53, 59, 60). However, these insects are not 
hematophagous and only incidentally bite humans (54). Many correlative studies have 
suggested that adult mosquitoes may serve as vectors of the bacilli (30, 61, 63, 162). The 
complex biology associated with the movement of pathogens from the mosquito gut to the 
salivary gland is appreciated during interaction with other pathogens. Unfortunately, there is no 
evidence that mosquitoes are biological vectors of bacterial diseases. However, mechanisms of 
mechanical transmission require far less biological interaction than salivary transmission. As an 
example, Francisella tularensis, the causative agents of Tularemia, has been shown to be 
mechanically transmitted by mosquitoes in some settings (163, 164). The overlap in the 
geographic distribution and the shared association with water between the A. gambiae and M. 
ulcerans highlights the potential interaction that may be occuring in nature.  
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Differences in vector competence among members of the Anopheles complex have 
been described and are attributed to differing preferences for feeding on humans versus 
animals, the tendency to enter structures, and an ability to recover after environmental 
disturbances. It is also suggested that interactions between host and pathogen influence the 
probability that mosquitoes are able to successfully transmit a pathogen. Interaction between 
mosquitoes and transmissible pathogens have been investigated in many systems, and the 
molecular consequences of this interaction are being characterized to discover novel strategies 
employed by both the mosquito and the pathogen that influence this dynamic. The mosquito 
attempts to control the internal development of pathogens, often resulting in immune 
stimulation and imposing a fitness cost. Many pathogens exploit mosquito systems to their 
advantage, resulting in increased probability of transmission and survival of the pathogen. 
While there are likely far fewer biological interactions occurring during instances of mechanical 
transmission compared to biological transmission, a study of the physiology of A. gambiae and 
M. ulcerans during varying spatial and temporal exposures will provide significant insight into 
mechanisms of pathogen control by the mosquito and immune evasion and persistence by the 














The pathogenesis of M. ulcerans infection is hypothesized to follow an initial 
contamination of the dermis, followed by replication of the bacilli in both an intra- and 
extracellular environment within the host subcutaneous tissue, concurrent with the production 
of a toxin that may contribute to necrosis of the tissue (72-76). Unfortunately, the contribution 
and presence of the toxin remains undefined during infection in humans. Therefore, we sought 
to characterize infection with a mycolactone negative isolate and compare the pathogenesis of 
disease in our mouse model to the human case definition. The disease originate as a nodule, 
papule, plaque, or localized edema, then progresses to ulcerative lesions. The lesions, if left 
untreated, result in debilitating complications from scarring with contracture to loss of limbs or 
vital organs (31, 49, 77).  
Multiple studies have used animal models to investigate infection with M. ulcerans (13, 
131, 165, 166). These studies have demonstrated the mouse and guinea pig susceptibility to 
infection with M. ulcerans, describing similar pathogenesis of disease to that seen in humans 
(167, 168).  To date, few studies have investigated M. ulcerans infection dynamics in 
immunodeficient mouse models (17). In order to better understand the mechanisms of 
persistence and immunosuppression, a comparison between wild-type and immunodeficient 
animals is advantageous. The aim of this present work is to characterize the host immune 
response and disease pathogenesis of a mycolatone-negative isolate by comparing 
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immunocompetent and immunocompromised mice after infection. The direct contribution and 
concentration of mycolactone in human lesions is not well described, and indeed it has been 
shown that the plasmid encoding this toxin is very unstable (169). A comparative investigation 
of the infection dynamics in immunodeficient and immunocompetent mice will provide insight 
into mechanisms employed by the pathogen irrespective of the contribution of mycolactone.   
M. ulcerans strains from different geographic regions have variable virulence 
phenotypes. This variability is commonly correlated with the synthesis (or lack of) of 
mycolactone isotypes or the ratio of isotypes. However, it is likely that other virulence factors 
play a significant role in pathogenesis. Our studies suggest cell-mediated immunity plays an 
important role in the outcome of disease, and that the host becomes immunosuppressed early 
in the course of infection during the asymptomatic stage of disease, irrespective of the 
presence of the toxin. Reactivation of disease into a severe, chronic state is characterized by an 
uncoordinated, cytokine-driven response, concomitant with antigen-specific pathogen 
recognition.  This supports the often conflicting data derived in human studies, and 
demonstrates that a systematic approach to understanding the immune response and its effect 
on BUD disease progression is required for further investigation of novel diagnostics and 
interventions for BUD. 
Materials and Methods  
Animals 
Eighty 8-week-old female wild-type C57BL/6J and immunocompromised B6.129S7-
Rag1tm1Mom/J (Rag-/-) mice were obtained from The Jackson Laboratory Center for Mouse 
Models of Heart, Lung, Blood and Sleep Disorders (Bar Harbor, ME). All mice were maintained 
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in the Animal Biosafety Level 3 facility at CSU, with sterile rodent chow and water ad libitum, 
with 5 animals per cage. The studies involving animals were approved by the Institutional 
Animal Care and Use Committee at Colorado State University, which is accredited by the 
Association for the Assessment and Accreditation of Laboratory Animal Care, International.  
Bacterial Strain and Culture 
M. ulcerans strain 94-511 was selected based on its virulence in humans (originally a 
clinical isolate from endemic Cote d’Ivoire), and its ease of culture and manipulation in multiple 
environments (24, 72). M. ulcerans 94-511 has been documented to produce mycolactone (72), 
although the strain used for this study was considered mycolactone negative. Confirmation that 
the strain was mycolactone-negative was achieved by whole DNA extraction from cells and an 
absence of a 174kb plasmid encoding the toxin, in addition to the absence of reactivity upon 
PCR analysis of the ketoreductase B (KR) domain of the polyketide synthase (mls) gene. For the 
preparation of the M. ulcerans inoculum, acid-fast bacteria (AFB) were grown at 32°C in static 
liquid Middlebrook 7H9 medium for approximately 1 month, or until the formation of a pellicle. 
The resultant pellicle was harvested and allowed to grow again at 32°C in low-mode shaking 
liquid Middlebrook 7H9 medium supplemented with oleic acid, albumin, dextrose, and catalase 
and (OADC)  for approximately 2 months. Cells were harvested via filtration from liquid media 
through 0.22µm membrane, acid fast stained, and counted in a hemocytometer for 
determination of concentration. A glycerol solution was added to a concentration of 10% and 





Mice were infected subcutaneously in the left hind footpad using a tuberculin syringe 
with 20µl containing approximately 6x106 AFB diluted in sterile water (using the right hind 
footpad as a control), or via aerosol with 6x106 AFB using a Middlebrook Aerosol Exposure 
chamber (GlasCol, LLC, Terre Haute, IN). The progression of disease was monitored with time 
points of 1, 7, 14, 28, 60, and 142 days post infection (DPI). At time points, animals were 
euthanized using CO2, their lung, spleen, draining lymph node (DLN) (popliteal), and footpad 
were removed, individually homogenized, and stored on ice for cytokine assays or immediately 
plated for CFU. 
Determination of Bacterial Burden 
M. ulcerans proliferation was assessed in infected mouse lung, spleen, draining lymph 
node (DLN) (Popliteal), and footpad tissues of infected mice at each of the previously described 
time points. Tissue specimens were aseptically harvested from euthanized mice into sterile 
tubes containing 4.5 ml of physiologic saline and briefly homogenized with a PRO250® 
homogenizer (PRO Scientific, Oxford, CT). Four 10-fold dilutions of each homogenate were 
spread onto plates containing Middlebrook 7H11 agar (Difco Laboratories, Detroit, MI) enriched 
with OADC. Plates were incubated at 32°C and CFUs counted after 4 months to ensure growth 
of all cells present. 
Cytokine concentrations in mouse tissues 
Identical volumes of tissue were collected from each animal at each time point. Tissue 
homogenates from the DLN, spleen, and footpad were briefly centrifuged for 10 minutes at 
1000xg to remove cellular debris. The supernatant was collected and assayed to determine 
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protein content with a bicinchoninic acid assay (BCA) (Pierce, Rockford, IL) and diluted to a 
working concentration of 1 mg/ml to standardize the protein concentration. The samples were 
then assayed in triplicate for the cytokines interleukin-2 (IL-2), IL-4, IL-5, IL-6, IL-10, IL-12, IL-13, 
IL-17a, IL-23, Interferon-ɣ (IFN-γ), tumor necrosis factor- α (TNF-α), and transforming growth 
factor-beta (TGF-β), and evaluated against tissue from uninfected control mice. After analysis a 
selection of cytokines are presented here.  The enzyme-linked immunosorbent assay (ELISA) 
(Qiagen) was used for detection of soluble cytokines in infected mouse tissues. Per the 
manufacturer’s instructions, samples were added to wells of an anti-mouse cytokine antibody 
coated plate. The plate was developed using and Avidin-HRP reporter and read using 
wavelength correction subtracting the reading at 450 nm from the reading at 570 nm. 
Histopathological Studies 
The DLN and footpads were harvested, fixed in 10% formalin, and embedded in paraffin. 
Sections were cut and stained with hematoxylin and eosin (H&E; IHC Tech, Aurora, CO). Digital 
microphotographs were taken using a Nikon Eclipse 51E microscope and a Nikon DS-Fi1 camera 
with a DS-U2 unit and NIS elements F software. Images are reproduced without manipulations 
other than cropping and adjustment of light intensity. 
Statistics 
Differences between the means of the CFU load of experimental groups and between 
the concentrations of individual cytokines, was analyzed at each time point using a two-tailed 
Student t-test, and a P value of ≤0.05 was considered significant. Pearson’s correlation analysis 




Mouse footpad inoculation results in an inflammatory condition of the skin whereas aerosol 
challenge does not 
Although aerosol exposure to Mycobacterium ulcerans represents an unlikely initial 
infection in human cases, many nontuberculous mycobacterial infections (NTM) demonstrate a 
tropism for the respiratory system (170). Aerosol challenge of wild-type C57BL/6 mice and the 
immunodeficient Rag-/- mice with virulent M. ulcerans resulted in a transient, asymptomatic 
infection, and perhaps a period of non-replicating persistence followed by death due to lack of 
nutrients (Figure 7C). Specifically, M. ulcerans was cultured from lung homogenates for up to 60 
Figure 7: Colony forming units (CFU) in mouse tissues during infection. *** denotes P≤0.001. 
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days post infection (DPI); no viable bacilli were recovered after this time point. Furthermore, up 
to 2 log10 colony forming units (CFUs) were also seen in the spleen and liver during the later 
time points (28 and 60 DPI), but not by 142 DPI following aerosol exposure (Figure 7). Our 
studies demonstrated no culturable M. ulcerans in peripheral blood, nor did the mice show 
clinical signs or external pathology representative of a cutaneous M. ulcerans infection during 
any point of the infection. However, the presence of disseminated M. ulcerans in the spleen of 
aerosol infected animals suggests hematogenous trafficking of bacilli. In contrast to aerosol 
infection, inoculation of the footpad resulted in measureable CFU throughout the course of 
infection monitoring. Organisms were observed in the footpad of Rag-/- mice throughout the 
course of infection, while in C57BL/6 mice there was a reduction in CFU at day 14, colonization 
persisted (Figure 7). Further, M. ulcerans was cultured in the draining lymph nodes in both 
immunocompetent and immunocompromised mice during the chronic disease state (Figure 
7B). M. ulcerans is known to grow preferentially at 32°C, in accordance with the cooler outer 
layers of the skin and peripheral tissues (171). In our studies, aerosol exposure and the 
subsequent respiratory infection of the mice was shown to result in a limited, transient 
infection, even in a severally immunocompromised model, consistent with the known biological 
tropism of M. ulcerans.  We therefore chose to pursue the footpad as the only route of 
exposure in our additional experiments. 
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Gross pathological features 
In human patients, the M. ulcerans bacilli are hypothesized to gain entry to the 
subcutaneous layers of the skin at the site of an existing wound or as a result of a puncture. 
Footpad inoculations of mice were performed using 5x106 M. ulcerans CFUs in a 20µl sterile 
water suspension. Injection of the bacterial suspension resulted in a slight wheal formation 
within the footpad. At 1 DPI, the footpad presented with mild edema and erythema in all mice, 
who also avoided using the mildly swollen foot. By 7 DPI the 
swelling had subsided to nearly that of baseline, and usage of 
the foot was unrestricted. These visual observations of the 
gross pathology continued until 28 DPI, when a reappearance 
of the mild edema and a more pronounced erythema was 
apparent.  Between 28 and 60 DPI, the swelling previously 
seen in the footpads was reduced to baseline appearance. By 
60 DPI, visible signs of infection were absent in all mice and 
mice appeared to use the inoculated foot without restriction. 
Neither did the mice appear to suffer from fatigue, malaise, 
and isolation as has been described in other mouse models of 
infection (172), although these variables were not individually 
tested. Mice developed a reactivation of disease after an asymptomatic period of 
approximately 50 days and by 142 DPI, all remaining mice were sacrificed due to edema and 
erythema of the footpad which had expanded proximally (Figure 8) compared to previous 
observations documented on 1 and 7 DPI, accompanied by severely restricted usage of the foot 
Figure 8a (top): dorsal lateral 
view of C57BL/6 hind footpads 
at 142DPI. Figure 8b (bottom): 
view of plantar surface of 
C57BL/6 hind footpads at 
142DPI showing proximal spread 
of inflammation in infected left 




and other signs of illthrift such as huddling, immobile disposition, and ruffled fur. Mice were 
sacrificed before the development of complete footpad ulceration for ethical reasons.  Few 
differences were observed in the gross pathology of either C57BL/6 or Rag-/- mice infected with 
M. ulcerans. Specifically, all mice presented with a similar pathological syndrome over the 
course of the infection, although there were differences in the type and kinetics of the 
pathology observed between the footpads of each strain (Figure 9A). 
Histopathological features 
Histological analysis of the infected footpad and DLN was performed to asses host 
immune cell recruitment and the condition of host tissues during infection.  Mice were infected 
with 5x106 M. ulcerans CFUs in a 20µl sterile water suspension in their left hind footpad and 
sacrificed periodically after infection to determine bacterial numbers in tissues (Figure 7). At 1 
DPI, the Rag-/- and C57BL/6 mice had a similar presentation, represented by focally extensive 
areas of dermal/subcutaneous edema and moderate to severe infiltration of 
polymorphonuclear neutrophils (PMN) and few macrophages. Muscle-fiber and collagen 
Figure 9a (left): Histology score of footpad tissue for pathology during infection. Figure 3b (right): Histology 
scores for immune cell infiltration into footpad tissues during infection. 
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degeneration was observed in both mouse strains, in addition to mild leukolytic necrosis of 
infiltrating PMN (Figure 10A). By 7 DPI, there was no statistical difference in CFUs between 
groups of mice. In addition, the popliteal lymph node was quiescent and histologically 
unremarkable until 7 DPI, when the C57BL/6 mice began to demonstrate reactive hypertrophy 
and hyperplasia with formation of secondary follicles and active germinal centers in the cortex 
and expansion of the paracortex (Figure 11). 
Figure 10: Representative footpad tissue micrographs with hematoxylin and eosin staining (H&E) from 
C57BL/6 (WT) mice demonstrating initial immune cell recruitment at 1DPI (10x)(A). Immune down-regulation 
resulting in normal appearance of footpad tissue at 28DPI (10x)(B), and 60DPI (10x)(C). Intense immune cell 
influx to footpad tissue resulting in edema and tissue necrosis by 142 DPI (4x)(D). 
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Rag-/- mice retained comparably small nodes composed of dense stroma and few discernible 
post-capillary venules (PCV) accompanied by mild and dispersed infiltration of the stroma by 
neutrophils (Figure 13).   
By 14 DPI, the immunocompetent C57BL/6 mice were able to mount an immune 
response against infection and reduce the bacterial load in the footpad by approximately 2 
log10. Immunodeficient Rag-/- mice were unable to mount an adaptive immune response and 
CFUs in footpad tissues increased by 1 log10 over the course of 28 DPI (Figure 7). The 
histological analysis displayed similar immune cell recruitment pattern between strains of mice. 
Figure 11: Representative popliteal lymph node micrographs with hematoxylin and eosin staining (H&E) from 
C57BL/6 (WT) mice demonstrating moderate neutrophil infiltration at 1 DPI (10x) (A). Moderately hypertrophic 
node containing secondary follicles and active post-capillary venules at 28 DPI (10x) (B). Hypertrophic node with 
several large secondary follicles and expanded paracortex at 60 DPI (10x) (C). Node with high cell density in all 
compartments by 142 DPI. Few secondary follicles with active germinal centers and deep paracortex containing 
high number of mature plasma cells (10x) (D). 
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The immunocompetent mice demonstrated a moderate recruitment of foamy macrophages 
focally in the dermis/subcutis of the pad, with mild edema and few lymphocytes and PMN 
diffusely throughout the interstitum. Similarly, immunodeficient mice presented with mild 
edema and a mild infiltration of macrophages and few PMN in a focally extensive area of the 
dermis/subcutis (Figure 12D).  
 
 
Figure 12: Representative footpad tissue micrographs with H&E staining from Rag-/- (immunodeficient) mice 
demonstrating initial immune cell recruitment at 1DPI (10x)(A). Immune downregulation resulting in 
histologically unremarkable appearance of footpad tissue at 28DPI (10x)(B), and 60DPI (10x)(C). Intense 
neutrophil infiltration to footpad tissue accompanied by sever tissue necrosis and collagen degeneration by 
142 DPI (4x)(D).  
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As expected, Rag-/- mouse lymph nodes remained small and underdeveloped, containing dense 
reticular stroma and small numbers of scattered PMN, mast cells, and foamy macrophages, 
with a notable absence of lymphocytes (Figure 13).  
During the period of 28 DPI to 60 DPI, a plateau of the CFU numbers in both strains of 
mice corresponded to a period of persistence of the bacteria. This plateau phenomenon, or 
persistence, has been documented in other mouse footpad infection models (173) . 
Additionally, during this time period, the infected footpads of both groups of mice progressed 
Figure 13: Representative popliteal lymph node micrographs with hematoxylin and eosin staining (H&E) from 
Rag-/- mice demonstrating dense cortical and medullary stroma, infiltrated by neutrophils and myeloid 
precursor cells at 1 DPI (10x) (A). Tiny node with foamy macrophages in medullary sinuses, few polymorpho-
nuclear cells at 28 DPI (10x) (B). Node with dense reticular stroma and few post-capillary venules. Small 
numbers of foamy macrophages and no apparent lymphocytes at 60 DPI (10x) (C). Node composed of loose 
vasculo-reticular stroma with scattered macrophages and few mast cells, and deep paracortex containing high 




from minimal, dispersed infiltration of primarily macrophages and few PMN, to a histologically 
unremarkable state (Figures 10B-C, 12B-C).  During this time course, some bacterial killing was 
apparent, although abundant bacilli were cultured from infected footpads, conflicting with the 
apparent down-regulation of the host immune response (Figure 9B).  
From 60 to 142 DPI, the bacterial load of the C57BL/6 footpad showed a dramatic 2 log10 
increase (Figure 7A). Lymph nodes of C57BL/6 mice exhibited the development of an advanced 
immune response represented by markedly hypertrophic expansion of both the cortex and 
paracortex. The former contained several large secondary follicles and the latter, many active 
PCV characterized by plumb endothelial cells and trans-endothelial lymphocyte migration, and 
mature plasma cells in the medulla (Data not shown). CFUs in the Rag-/- footpad remained in a 
persistent, plateaued state during this time period (Figure 7A).  
By 142 DPI, CFU levels in the footpads of both strains of mouse were identical (Figure 
1A). In the wild type C57BL/6 mouse, the CFUs increased 2 log10 over the steady state described 
from 14 through 60 DPI, to a level statistically indistinguishable from the immunodeficient Rag-/- 
mouse. This final time point of 142 DPI comprised mice which had failed to control the infection 
at a level comparable to immunodeficient mice.  All mice presented with severe disease, on 
both a histological (Figures 10-13) and gross pathologic level (Figure 8). Within the dermis and 
subdermal tissue of C57BL/6 mice, focally and involving musculature, there was moderate to 
marked edema, marked infiltration of monocyte-macrophages, moderate PMN infiltration and 
multifocal tissue necrosis. Within the C57BL/6 lymph node, high cell density was apparent in all 
compartments. There were few secondary follicles, all with active germinal centers, occasional 
PCV appeared with hypertrophic endothelium and the medullary cords and deep paracortex 
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contained large numbers of mature plasma cells. Comparably, Rag-/- mice presented with more 
severe disease, encompassing most of the soft tissues of the foot (dermis, musculature, nerves, 
periost). There was severe tissue necrosis with loss of identifiable musculature, infiltration of 
predominantly PMN with an admixture of fewer macrophages and scattered mast cells. Blood 
vessels within the affected tissue appeared with leukocytosis, leukocyte margination, 
transmural infiltration and occasionally fibrinoid necrosis. In a focally extensive area of the 
footpad of one mouse, the inflammation and tissue necrosis extended to and involved the 
epidermis with formation of a scab mainly composed of necrotic epithelium and 
degenerate/effete PMN. The underlying dermal collagen was undergoing degeneration (Figure 
10D).   
Mouse cytokine production can be correlated to disease state as a marker of disease progress 
Infection with M. ulcerans in humans and mice induces a local inflammatory response 
that is characterized by the induction of cytokines such as tumor necrosis factor (TNF)-α, 
interferon (IFN)-γ, interleukin (IL)-1, IL-12 and IL-15 (139) characteristic of a Th1 immune 
response. Indeed it has been suggested that a Th1 immune response to M. ulcerans may 
prevent the development of BUD in people exposed to M. ulcerans, while a Th2 response does 
not (140). To identify immunological correlates of infection, we performed a broad screen of 
soluble cytokines from infected mouse tissues (Figure 14). Using a multi-analyte profiling 
approach, we compared the levels of soluble, inflammatory cytokines in the mouse footpad 
homogenates between mouse strains during the development of active infection. Additionally, 
selected cytokine concentrations were measured in the spleen, DLN, and whole blood serum at 
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the final time point of 142 DPI using a similar approach. By 7 DPI both strains of mice responded 
with higher secretion of IL-6 and IL-12 in the footpad homogenates relative to other measured 
cytokines, and at similar levels (Figure 14C and D). Other cytokines, particularly TNF-α and IFN-
γ, demonstrated similar abundance between groups of mice, and occurred at a low level 
compared to other measured cytokines (Figure 14A and B). During the time course of 14 DPI 
through 28 DPI, measured cytokines appeared to decrease from initial measured levels and 
plateaued, which correlated with the pattern observed in the CFU numbers during this time 
period. By 60 DPI, C57BL/6 mice demonstrated an increased secretion of multiple cytokines, 
relative to the initial stages of infection. IL-6 and IL-12 rose to concentrations measured in 
Figure 15: concentration (pg/ml) of IL-6 
(A) and IL-12 (B) measured over time.  
* denotes P≤0.05 
A B 
C D 
Figure 14: Concentration (pg/ml) of selected cytokines in mouse footpad tissue homogenates over the course 
of infection. Data point represents experimental mean with standard deviation. * denotes P≤0.05 
45 
 
earlier time points, while IFN-γ demonstrated a nearly 6-fold increase relative to the 
measurement at 1, 7, 14, or 28 DPI [e.g. 1DPI-IFN-γ: 90.6pg/ml, 60DPI-IFN-γ: 492.7pg/ml, 
experimental mean, n=5]. The increased IFN-γ levels in the C57BL/6 mice correlated with the 
reduced bacterial burden documented at this time point.  
 As described previously, at the terminal time point of 142 
DPI similar gross and histo-pathological conditions were 
apparent in both strains of mice (Figures 10D, 12D). While 
other measured cytokines remain at a low level, a significant 
decrease in the production of IFN-γ was documented in 
C57BL/6 mice relative to that measured at 60 DPI [C57BL/6: 
60DPI-IFNγ: 492.7pg/ml, 142DPI-IFNγ: 34.98pg/ml, 
experimental mean, n=5], although at statistically 
indistinguishable levels between strains of mice in the 
various tissues (Figure 15A), and strongly correlates with the 
rising CFU burden and histological measurements of strong 
disease activity. The concentration of TNF-α in the measured 
tissues demonstrates significant differences between strains 
of mice by the final time point (Figure 15B). By 142 DPI, CFU levels in immunocompetent mice 
rose from a plateau to a level statistically indistinguishable from Rag-/- mice over the same time 
period, perhaps due to the down-regulation of protective cytokines.  
 
 
Figure 15: comparison of the 
concentrations (pg/ml) of IFN-ɣ (A) 
and TNF-α (B) in various tissues 
between strains of mice at the 




 The data from the current study demonstrates the development of active infection after 
experimental inoculation of the mouse footpad that parallels the suspected human route of 
exposure and subsequent presentation of disease, without the contribution of the toxin 
mycolactone. While this mycolactone-negative strain appears attenuated in the wild-type 
C57BL/6 mice, a finding consistent with other mouse footpad models (174), the mice presented 
with degrees of pathology over time, eventually resulting in severe disease regardless of the 
immune state of the host.  Mice of both immunological states rapidly developed necrosis of 
footpad tissues and destruction of the limb, as described previously (165), after a lengthy and 
variably asymptomatic period of time. Many publications of virulent M. ulcerans pathogenesis 
in experimental infections report extensive inflammatory cellular infiltrates to the lesion (2, 
163, 164), consistent with our model. Indeed, the pattern of immune cell recruitment we have 
described is consistent with the finding of Oliveira et. al. (2005), who described strong initial 
recruitment of neutrophils followed by monocytes, to be a feature of M. ulcerans infection 
unrelated to the isolate’s virulence (168). Other publications report minimum or absent 
inflammation in the lesion (30, 134), together with rapid progression into an ulcerative state.  
Taken together, this opposition provides evidence linking the contribution of other virulence 
determinants and variable bacterial phenotypes that still result in necrotizing pathogenesis. 
These studies also highlight a major obstacle in the understanding of M. ulcerans biology. The 
infectious phenotype of different eco-varieties of the pathogen demonstrate significant 
variability, even more so when comparing pathogenesis in distinct genotypes of mice (17). In 
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general, from this study, we were able to obtain valuable insights into the disease progression 
and the relationship with expression of immunity. 
 Immunocompetent mice were able to mount an immune response to the bacteria 
during this time, supported by the recruitment of immune cells into footpad tissue, the 
production of cytokines, and the initial decrease in bacterial load of the footpad. The pattern of 
immune cell recruitment during disease in the immunocompetent C57BL/6 mice is consistent 
with other reports in both mice and humans, in that the initial immune response is 
characterized by strong neutrophilic infiltration and a transition to a monocytic/macophagic 
infiltration during later stages (175). The histologic identification of immune cell necrosis and 
collagen degeneration occurring in the absence of mycolactone production was surprising. This 
finding supports the conjecture that virulence is not solely determined by the action of the 
toxin.  
 At the terminal time point of 142 DPI, the ensuing infection of the mice resulted in a 
severe inflammatory state characterized by a significant increase in bacterial burden and the 
disappearance of Th-1 driven, potentially protective IFN-γ and IL-12 production.                        
The recruitment of host inflammatory cells was most dramatic at this final time-point. In 
addition to the abundance of inflammatory cell infiltrates, extensive tissue necrosis and 
degeneration of musculature and collagen characterized the severe pathology that precedes 
ulceration.  
 All animals eventually succumbed to infection, regardless of immune status, 
supporting the conjecture that BUD pathogenesis is not entirely dependent on immune status, 
co-infection, or the presence of the toxin (176). And while the two models end up with the 
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same outcome, the path to this outcome differs between strains of mice.  The detailed 
histological analyses described here demonstrate that in the absence of mycolactone, cellular 
infiltration drives BUD pathology in the later, chronic disease state (Figures 10D, 12D). Analysis 
of soluble cytokines in the lesions revealed high IL-6 expression in both C57BL/6 and Rag-/- mice 
(Figure 14), and an inverse relationship between IL-6 and IFN-γ.  IL-6 was shown to increase 
when IFN-γ decreased in the C57BL/6 mouse and appears to be continuously elevated in the 
Rag-/- mouse in the absence of IFN- γ. An over production of IL-6 has been associated with 
severe, chronic inflammatory diseases (177), and has been reported as a differentially regulated 
cytokine in BUD patients compared to community controls (178). Additionally, IL-6 has been 
documented as a marker of innate immune activation in clinical specimens of BUD patients 
(137). Indeed, high levels of IL-6 have been reported to enhance other mycobacterial infections 
such as Mycobacterium avium, when occurring both intra- and extracellularly (179, 180). The 
abundant infiltration of neutrophils and monocytes to lesions in our model is consistent with 
the role IL-6 has in the augmentation of cell adhesion molecules and neutrophil transmigration 
(181), suggesting that IL-6 drives leukocyte recruitment to the lesion.  
 Our results indicated a mechanism of localized immunosuppression in concordance 
with immune cell infiltration in C57BL/6 mice.  While other immune avoidance strategies of M. 
ulcerans have been thoroughly described (73), the specific role of IL-6 in this system requires 
further study. Defects in antigen processing and presentation of macrophages, specifically 
suppressing cell-mediated immunity as a result of over-expressed IL-6, have been documented 
(182).  The source of IL-6 induction remains unclear, as TNF-α was not demonstrated to be a 
significant factor during the course of infection. Previous studies described mycobacterial cell 
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wall components such as muramyl dipeptide and lipoarabinomannan as responsible for 
inducing IL-6 production in other models (183, 184), suggesting that a mycobacterial product 
may be involved with IL-6 induction in our model. The up-regulation of IL-6 and IL-12 
demonstrated here may represent novel biomarkers of M. ulcerans infection which may be 
further explored and eventually developed and applied to detect risk of development of BUD.   
 The pathologic state of the C57BL/6 mice during reactivation of disease (>140 DPI), 
represents a failure to adequately control the infection, despite a fully complemented immune 
system, in our model of BUD. Additionally, the absence of IL-4 and IL-5 in our model would 
suggest that Th-2 immunity did not play a role in the development or reactivation of disease. 
Thus, it appears that the Th-1/Th-2 paradigm does not apply here, as has been seen with other 
mycobacterial infections (185, 186). The molecular mechanisms involved in 
immunosuppression and the activation and subsequent degeneration of T cells is in need of 
further characterization, but could represent a crucial piece of understanding of the immune 
evasion strategies of M. ulcerans.  
 Finally, this study demonstrates significant immunosuppression and persistence of 
the M. ulcerans bacilli without the contribution of mycolactone. The characterization of 
additional virulence factors affecting disease progression with or without the presence of 














 M. ulcerans is a known environmental pathogen, but its specific niche and the 
mechanism of maintenance in the environment remains unknown (187). The source of 
transmission of the pathogen is also unknown, but many aquatic invertebrates have been 
implicated in this process (161). The primary risk factors in the development of disease are a 
close association with standing or stagnant water, the use of protective clothing, and 
inadequate wound management (188). Reports of M. ulcerans DNA contamination of wild-
caught mosquitoes and the successful culture of live M. ulcerans from predatory water bugs 
(Naucoridae, Belostomatidae) have led the initiation of a plethora of studies investigating the 
association between M. ulcerans and aquatic invertebrates (48, 52, 53, 59, 60, 62, 189).   
 Anopheles gambiae, the infamous malaria vector, is commonly found in regions 
endemic to Buruli Ulcer disease, especially in sub-Saharan Africa (190). A. gambiae larvae 
develop in small, diverse bodies of water and filter bacteria from the water column as a source 
of nutrition. The aquatic lifestyle of the Anopheline mosquito, both as larvae and adults, 
potentiates the hypothesis that these mosquitoes could also be associating with natural 
populations of M. ulcerans. In this study, we investigate the association between these two 
organisms and the role A. gambiae may play in the transmission and maintenance of M. 
ulcerans through the use of laboratory models of transmission and a thorough investigation of 
the contamination of the insects. Previous studies have investigated the interaction between 
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M. ulcerans and other genera of mosquitoes, specifically describing a positive correlation 
between disease incidence in Victoria, Australia and M. ulcerans-DNA contamination of wild 
caught mosquitoes. Within the laboratory, a landmark study by Wallace et al. (2010) described 
the interaction among multiple genera of mosquitoes, wild-type and toxin-negative M. 
ulcerans, and the implications this interaction has in ecological trophic relationships (54). 
However, this study lacked an analysis of the interaction between M. ulcerans and any of the 
ubiquitous members of the Anopheles genus. The study described here includes a similar 
analysis of the role of A. gambiae to transmit and maintain the M. ulcerans pathogen within the 
laboratory and the implication of such interaction.  
Materials and Methods 
Mosquito growth 
1st-instar larval mosquitoes were acquired from the colony maintained at the 
Arthropod-borne Infectious Disease Laboratory (AIDL) at Colorado State University. 100 larval 
mosquitoes were distributed to individual cages containing 250ml of sterile water and 
supplemented daily with finely ground fish food.  All cages were setup in duplicate for the 
individual treatment groups and each experiment was repeated in triplicate. Mosquitoes were 
monitored daily and allowed to develop over a period of 10 days in a controlled environment of 
28°C and 70% humidity. Mosquito cages were supplemented with sterile water and raisins, ad 
libitum, upon emergence of adult insects. Upon termination of the study, adult mosquitoes 
were aspirated from the cages and knocked down in 4°C. 10 mosquitoes each were distributed 




 Mycolactone-negative Mycobacterium ulcerans strain 1615-GFP was kindly donated 
by Dr. Pamela Small from the University of Knoxville, Tennessee. The culture was propagated at 
32°C for a period of 3 weeks on Middlebrook 7H11 (Difco Laboratories, Detroit, MI) plates 
supplemented with Kirschner Selecta-Tabs and 10 µg/ml kanamycin (7H9+), then aliquoted into 
infectivity stocks at a concentration of 1010 cells/ml. Expression of GFP was confirmed in the 
final culture with a fluorescent microscope. Contaminating bacteria from mosquito samples 
were acquired by vortexing the tissues of interest in 7H9+ liquid media, performing a 10-fold 
serial dilution and plating the dilutions on Middlebrook 7H11 plates with supplements as 
described.    
Mosquito treatment groups 
 100 1st-instar larval mosquitoes were exposed, in duplicate, to live and dead 
supplemental bacteria, or no supplemental bacteria. 102 cells/ml of live M. ulcerans 1615-GFP, 
102 cells/ml of dead, ɣ-irradiated M. ulcerans 1615-GFP, and dead, ɣ-irradiated Mycobacterium 
tuberculosis were added to the sterile water upon the addition of larval mosquitoes. All groups 
received approximately 100 mg of fish food daily, in addition to the single dose of supplemental 
bacteria. 
Mosquito survival and fitness 
 The mosquito’s survival to adulthood was measured by counting the number of 
emerged adults and generating a Kaplan-Meier survival curve among the treatment groups. The 
relative fitness of emerged adults was evaluated by measuring the wing size of emerged 
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mosquitoes as a proxy for body size. Both wings were removed and measured electronically via 
the publicly available ImageJ program (imagej.nih.gov/ij/) using a line measurement plugin.  
DNA extraction of bacilli from mosquito tissues 
 Mosquitos were collected and dried for 30 minutes under a vacuum. After this time, 
500ul of liquid N2 was added and the mosquitoes were incubated for 30 seconds. Dryed insects 
were homogenized 100 µl sterile DNase/RNase free water with a handheld Eppendorf 
homogenizer then centrifuged at 10,000xg for 10 minutes to remove debris. The supernatant 
was retained and 100 µl of 1M HCl was added and incubated for 30 minutes at room 
temperature for decontamination, then subsequently neutralized by adding an equal volume of 
1M HCl. DNA was extracted and purified using diatomaceous earth, as described (191). Briefly 
50 µl of the decontaminated sample was added to 50 µl of lysis buffer L6 (120g guanidinium 
thiocyanate (GuSCN) (Fluka Chemie; Buchs, Switzerland) dissolved in 100 ml 0.1M Tris-HCl at pH 
6.4, with 22 ml 0.2M EDTA and 26g Triton X-100 (Sigma Aldrich; St. Louis, MO) and stirred 
overnight) in a clean Eppendorf tube and briefly mixed. 10 µl of proteinase K (20 mg/ml) was 
added before an overnight incubation at 60°C in a shaking incubator. To capture DNA, 10 µl of 
diatomaceous earth stock solution (10g diatomaceous earth (Sigma Aldrich; St. Louis, MO) in 50 
ml H20 containing 500ul of 37% (wt/vol) HCl), then placed in a shaking incubator for 2 hours. 
Mixed samples were then centrifuged at 5000xg for 5 minutes. The resultant pellet was twice 
washed with 200 µl of L2 buffer (120 g GuSCN in 100 ml 0.1M Tris-HCL pH 6.4), then centrifuged 
and the pellet washed first with 70% ethanol, then 200 µl acetone. The washed pellet was dried 
under vacuum then resuspended in 20 µl TE buffer and incubated for 20 minutes at 65°C. After 
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incubation, samples were centrifuged at 2000xg for 5 minutes and the supernatant transferred 
to a sterile, PCR grade 1.5ml tube.  
PCR analysis of extracted DNA 
 PCR analysis was performed as described (192). Primers for the amplification were 
MU1 (5’-GGCAGGCTGCAGATGGCAT-3’) and MU2 (5’-GGCAGTTACTTCACTGCACA-3’) directed 
against the IS2404 sequence and producing at 549-bp fragment in the presence of M. ulcerans 
DNA. Briefly, 2 µl samples of purified DNA were amplified in buffer supplied by the 
manufacturer of Taq polymerase (Roche, Indianapolis, IN) in 20 µl reaction mixture containing 
1U of Faststart Taq polymerase, 1 uM primers, 1.5 mM MgCl2, and 200 uM (each) 
deoxynucleoside triphosphates. Amplification occurred in an automated thermal cycler (MJ 
Research) with the following conditions: denaturation at 94°C for 2 minutes, amplification by 35 
cycles of 1 minute steps at 94, 66, and 72°C, and final extension at 72°C for 7 minutes. 15 µl of 
the completed reaction were run on at 1.5% agarose gel in Tris-borate-EDTA buffer stained with 
SYBR safe DNA stain (Life Technologies, Grand Island, NY), and visualized with UV 
transillumination on a gel-doc XR+ system (Biorad) using Image Lab software. 
Immunofluorescence 
10 larval and 10 adult female mosquitoes from each treatment group were subjected to 
immunofluorescence (IFA) screening of internal and external tissues for contamination by M. 
ulcerans. The head, midgut, and salivary glands of adult female mosquitoes were removed and 
immediately placed in 4% paraformaldehyde solution for 10 minutes for fixation and washed in 
phosphate buffered saline (PBS). After fixation, the tissues were permeabilized by the addition 
of 0.1% Triton X-100 for 10 minutes and washed in PBS. To distinguish between green mosquito 
55 
 
auto-fluorescence and the GFP expressing bacilli, tissues were first probed using a rabbit anti-
M. ulcerans whole cell antibody developed at Colorado State University. The anti-M. ulcerans 
antibody was then probed with a goat anti-rabbit Cy5 labeled antibody (Life Technologies). 
NucBlue DAPI nuclear stain (Life Technologies) was applied for a period of 5 minutes as a 
counter-stain. Fluorescently labeled tissues were viewed by epifluorescence microscopy 
(Olympus, Center Valley, PA) equipped with a standard epifluorescent attachment filter set. 
Larval mosquitoes were removed from the development cages and immediately placed in 4% 
paraformaldehyde for fixation. Larval mosquitoes were viewed with epifluorescent microscope 
scope as previously described, without additional fluorescent labeling. Images are reproduced 
without alteration besides cropping and adjustment of light intensity.  
Transmission experiments 
 Adult female mosquitoes from each treatment group were analyzed for their ability 
to mechanically transmit the contaminating M. ulcerans bacilli. Firstly, the heads of adult 
female mosquitoes were removed and assayed to confirm the presence or absence of live M. 
ulcerans bacilli as described. A second set of 10 adult female mosquitoes were used for saliva 
collection, a third set of 10 adult female mosquitoes were used for an artificial blood meal, and 
a fourth set of 20 adult female mosquitoes were used for a blood meal from C57BL/6 mice.  
 For saliva collection, 10 adult female mosquitoes were collected from each 
treatment group and anesthetized by a 5 minute exposure to a cotton ball soaked with 
triethylamine (Sigma Aldrich). The wings and legs were removed from the mosquito bodies and 
the proboscis was placed into a capillary tube containing 7H9+ media. Mosquitoes were 
allowed to salivate into capillary tubes for 45 minutes. After this time period, mosquitoes were 
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removed from the capillary tube and the tube was placed into a cryovial containing 100 µl 7H9+ 
media and centrifuged at 1,000xg for 10 minutes. The resulting sample was divided in half; with 
half subjected to DNA extraction and PCR analysis for the M. ulcerans insertion sequence 
IS2404. The remaining half was 10-fold serially diluted, plated on 7H11+ plates and incubated as 
described.  
 For the artificial blood meal, 10 adult female mosquitoes were collected and placed 
into a clean carton with a mesh lid 24 hours in advance of the experiment, with clean water and 
raisins provided ad libitum. Approximately 4 hours before the experiment, the food and water 
were removed to encourage feeding. A temperature controlled water flow mechanism (VWR 
Radnor, PA) was connected to a glass blood meal apparatus. A hydrated hog gut membrane 
was attached to the bottom of the glass apparatus and the device was filled with 100 µl 
defibrinated sheep blood. Mosquitoes from all treatment groups were allowed to feed on 
individual artificial blood meal devices for approximately 1 hour. After the artificial blood meal 
apparatus was placed on the cages, mosquitoes were stimulated to feed by exhaling breath 
over the cages. After feeding, the defibrinated blood was collected, divided in half, and assayed 
in a similar method as the saliva collection.  
Mouse Transmission 
 For the mouse blood meal, 20 adult female mosquitoes were collected, divided, and 
placed into a clean carton with a mesh lid to make duplicate groups of 10 mosquitoes per 
treatment group. Eight C57BL/6 mice were gently anesthetized by an intraperitoneal injection 
of 100 µl ketamine-xylazine solution (100 µl ketamine, 75 µl xylazine, 825 µl PBS) and allowed 
to rest for 10 minutes. The anesthetized mice were placed onto the mesh lid of the mosquito 
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cage and remained in place for approximately 1 hour. A separate group of mice received an 
inoculation of 106 M. ulcerans cells in a 10ul inoculation into the tail. An additional control 
group of mice received a mock puncture inoculation in the tail using a 22 gauge needle dipped 
in a suspension of M. ulcerans. Every 14 days post inoculation or mosquito blood meal, a 20ul 
blood sample was collected from the tail vein of all mice. Blood was allowed to clot and the 
sera was retained for western blot analysis against M. ulcerans whole cell lysate.  
Statistics 
 Statistical significance of the survival and fitness data was determined using a two-
sided student’s t-test between individual treatment groups.   
Mouse Care 
Twenty 8-week-old female wild-type C57BL/6J mice were obtained from The Jackson 
Laboratory Center for Mouse Models of Heart, Lung, Blood and Sleep Disorders (Bar Harbor, 
ME). All mice were maintained in the Animal Biosafety Level 2 facility at CSU, with sterile rodent 
chow and water ad libitum, with 5 animals per cage. The studies involving animals were 
approved by the Institutional Animal Care and Use Committee at Colorado State University, 
which is accredited by the Association for the Assessment and Accreditation of Laboratory 








Within the aquatic environment, larval 
mosquitoes are known to filter bacteria from the water 
column as a source of nutrition. During mosquito 
development in the contaminated water, A. gambiae 
larvae readily consume the M. ulcerans bacilli, 
measured by fluorescent microscopy of the larval 
alimentary canal (Figure 16). Larval mosquitoes readily 
consume supplemental bacteria, but the effect on 
survival and development of adult mosquitoes is only 
encountered in groups consuming live M. ulcerans.  
Upon emergence from the aquatic environment, adult mosquitoes remain in contact with the 
contaminated water source. To determine the contamination patterns of adult mosquitoes, 
emerged adult female mosquitoes were collected, fixed, and fluorescently labeled. Since most 
vector-borne pathogens are transmitted by mosquitoes via salivary expression into the 
puncture wound, we first analyzed the salivary glands of adult female mosquitoes and 
discovered no measurable contamination by M. ulcerans using IFA. The salivary glands were 
also homogenized and subjected to PCR against the M. ulcerans insertion sequence IS2404 and 
culture. We found no contamination of the mosquito salivary glands using this approach. 
Additionally, analysis of the midgut tissues revealed no contamination by M. ulcerans.  
Figure 16: Alimentary canal of larval A. 
gambiae mosquito packed with M. 
ulcerans 1615-GFP, viewed under a 
fluorescent microscope (10x). 
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A microscopic analysis of the distal end of the female mosquito’s proboscis reveals a 
complex tissue structure composed of chitinous scales and sensory hairs. IFA analysis of this 
structure demonstrated intense contamination by M. ulcerans bacilli (Figure 17). These 
contaminating bacilli are active and demonstrate positive growth upon culture (data not 
shown). The length of time that the contaminating M. ulcerans remains alive on the mosquito 
mouthparts was not measured.  From these data, it could be suggested that mosquitoes may 
transmit the bacilli through a mechanical mechanism, as opposed to the common biological 
mechanism of other pathogens. All mosquitoes sampled from the live M. ulcerans groups 
demonstrate this external pattern of contamination. The ɣ-irradiated M. ulcerans and M. 
tuberculosis groups do not show a similar pattern of contamination, although few ɣ-irradiated 
M. ulcerans cells could be detected on the mosquito mouthparts.  
Figure 17: Immunofluorescence image of labral tissues of mosquito proboscis at 40x magnification. M. 
ulcerans bacilli (labelled in red) contaminated these external structures (left). High contrast microscopy of 
labral tissues of proboscis for reference (right).  
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An analysis of survival to adulthood among the treatment groups reveals a significant 
difference in survival among the treatment groups. As a source of nutrition, the ɣ-irradiated M. 
ulcerans and M. tuberculosis bacilli provide a significant increase in survival compared to the 
control groups, which rely solely on fish food. Conversely, mosquitoes which have consumed 
live M. ulcerans bacilli during development are measured to have a significantly reduced 
survival rate compared to the controls (Figure 
18).  In addition, the emerged adult 
mosquitoes are significantly smaller than 
their counterparts which have consumed 
control fish food and ɣ-irradiated bacilli 
(Figure 19).  Interestingly, when M. ulcerans 
bacilli are used as a monotypic food source 
(without supplemental fish food), the effect 
on the larval mosquitoes is lethal (data not 
shown). According to our study, this effect 
S u r v iv a l A v e ra g e s  A m o n g  A ll G ro u p s






















C o n tro l
M u (L iv e )
M u (D e a d )
M u -M o s q u ito  S u rv iv a l to  A d u lt  S ta g e



















M u (L iv e )
M u (D e a d )
***
Figure 18: Kaplan-Meier plot of Survival to adulthood for mosquitoes from all treatment groups (left). 
Individual M. ulcerans (Mu) exposed treatment groups separated for comparison revealing a significant 
difference in survival (right). ***= p.001  
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Figure 19: Comparison of the wing size of emerged 
female mosquitoes as a proxy for body size. Adult 
mosquitoes are significantly smaller than their control 
counterparts as a result of exposure to live M. ulcerans.   
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seems to be specific to A. gambiae mosquitoes, as Culex sp. mosquitoes can consume live M. 
ulcerans bacilli as a monotypic food source, even in concentrations as high as 1010 cells/ml 
without any measured developmental effects or reduced survival (data not shown).    
To determine if the contaminated 
mosquitoes could mechanically 
transmit the bacilli, contaminated 
mosquitoes were collected and saliva 
was extracted. The collected samples 
were then interrogated for the 
presence of M. ulcerans via PCR 
against the IS2404 sequence and 
culture. This procedure did not detect 
any replicating bacteria in the 
collection medium via culture (data 
not shown). The PCR analysis results 
were positive for the presence of M. 
ulcerans DNA in the saliva sample, as expected (Figure 20; Lanes 9,10), by the presence of a 
549-bp band. No contaminating bacilli or M. ulcerans DNA was detected in the saliva collected 
from the control mosquitoes (data not shown). 
To further refine the transmission hypothesis, contaminated and control mosquitoes 
were allowed an artificial blood meal through a hog-gut membrane and by feeding on 
anesthetized mice. After demonstrating the positive contamination of adult female mosquitoes 
Figure 20: PCR analysis of experimental samples. Lanes:  
1: high mass DNA ladder  
2: control mosquito homogenate (negative control)  
3: M. ulcerans gDNA (1ug) (positive control) 
4: Mosquito homogenate spiked with M. ulcerans gDNA (1ug) 
5: homogenate of mosquitoes exposed to M. tuberculosis 
6: homogenate of mosquitoes exposed to M. tuberculosis 
spiked with M. ulcerans gDNA (1ug) 
7: homogenate of mosquitoes exposed to live M. ulcerans 
8: homogenate of mosquitoes exposed to dead M. ulcerans 
9: saliva sample from mosquito exposed to live M. ulcerans 
10: saliva sample from mosquito exposed to dead M. ulcerans 
11: low mass DNA ladder 
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from the same group (Figure 21: Lanes 6,8), 
the remaining mosquitoes were placed in a 
clean cage as described. The mosquitoes 
and the defibrinated blood were collected 
and analyzed. Subsequently, mosquito 
tissues did not demonstrate growth of live 
M. ulcerans upon culture but remained PCR 
positive (Figure 21: Lane 7). The collected 
blood did not demonstrate positive culture 
or PCR signals after the feed (Figure 21: 
Lane 5). Contaminated and control 
mosquitoes were also allowed to feed on 
anesthetized mice for a period of 1 hour. 
The subsequent analysis of mosquito 
exposed mouse serum demonstrated no reactivity to whole cell lysate via western blot over a 
period of 20 weeks (data not shown). Mice inoculated with the sham needle puncture did not 
develop antibodies against M. ulcerans antigens during the study period 
Discussion 
Due to the significant overlap in the geographic and environmental distribution of both 
A. gambiae and M. ulcerans, it is highly likely that these two organisms interact on some level. 
Other studies have demonstrated an association between mosquitoes and outbreaks of Buruli 
Ulcer disease (61). Indeed, the use of bed nets has been shown to reduce the risk of infection 
Figure 21: PCR analysis of samples from transmission 
experiments. Lanes: 
1: high mass DNA ladder 
2: control mosquito homogenate (negative control) 
3: M. ulcerans gDNA (positive control) 
4: water sample from live M. ulcerans mosquito cage 
5: defibrinated blood after artificial blood meal of 
mosquitoes exposed to live M. ulcerans 
6: homogenate of mosquito exposed to live M. ulcerans 
before artificial blood meal 
7: homogenate of mosquito exposed to live M. ulcerans 
after artificial blood meal 
8: homogenate of mosquito exposed to live M. ulcerans 
before mouse blood meal 
9: homogenate of mosquito exposed to live M. ulcerans 
after mouse blood meal 
10: M. ulcerans gDNA (positive control) 
11: low mass DNA ladder  
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with M. ulcerans. Unfortunately, the role mosquitoes play in the transmission and maintenance 
of M. ulcerans in the wild remains elusive. In this study, we report two distinct contamination 
patterns of A. gambiae mosquitoes. Larval mosquitoes readily consume introduced M. ulcerans, 
and may serve as a bioaccumulator of the pathogenic bacteria in the wild. A study by Mosi et al 
(2008), demonstrated the contamination of the raptorial arms of predacious water bugs after 
the consumption of contaminated mosquito larvae, further encouraging the role of mosquitoes 
in the passage of M. ulcerans through the aquatic food web (52). In this study, we show larval 
mosquitoes can successfully maintain live, active M. ulcerans in their alimentary canal during 
their development. Larval mosquitoes are a prominent member of the aquatic food chain, and 
are eaten by a wide variety of higher order insects, amphibians, birds, and fish. The association 
between larval mosquitoes and M. ulcerans bacilli may represent a ubiquitous mechanism of 
maintenance of the bacteria in the natural setting. However, it is not likely that mosquito larvae 
would be exposed to the concentration of bacilli used in this study while developing in their 
natural habitat, although the actual distribution and concentration of M. ulcerans in the wild in 
unknown.       
Once emerged from the water column, adult mosquitoes must still associate with the 
aquatic environment for breeding and hydration. The appearance of contaminated bacilli on 
the external structures of the adult mosquito and the lack of internal contamination of gut and 
salivary glands suggests that contamination of the adult mosquitoes occurs post emergence 
from the aquatic stage of development. These emerged, contaminated mosquitoes are small 
and may be more likely to be eaten by higher predators. While it may seem disadvantageous 
for the pathogen to negatively affect the development of the mosquito, it further promotes the 
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idea of a biological relationship between the two organisms. However, it is unknown whether 
the fitness cost from the association with the live M. ulcerans is due to larval consumption of 
the bacilli, the external contamination of the adults, or through some other mechanism. Size of 
the adult mosquito can influence epidemiologically relevant traits, thus the probability that 
mosquitoes actively transmit the contaminating pathogen is low (193). Although, it could be 
suggested that contaminated mosquitoes with reduced fitness may also contribute to 
environmental maintenance of the bacilli. 
Our transmission studies further 
implicate mosquitoes’ role in 
maintenance and not as a vector. In our 
model, the contaminated mosquitoes 
were not able to measurably transmit the 
pathogen (Figure 22). While the true 
infective dose is unknown, it is highly 
likely that a potential dose received from 
a mosquito would contain very few, if any, cells. The mouse model of transmission did not 
demonstrate any measurable immune recognition of the pathogen potentially vectored by the 
mosquitoes. Our mouse transmission study models the potential transmission of bacilli from 
contaminated mosquitoes to fully immunocompetent mice. However, it is suspected that the 
nutritional status or general health of human populations plays a significant role in their 
susceptibility to M. ulcerans infection, and the inclusion of an immunosuppressed model would 
be advantageous. Epidemiological studies in the field have not been able to definitively 
Figure 22: The position of the adult female anopheles 
mosquito during a blood meal. Arrow indicates the 
anatomy of the proboscis and labral tissues during the 
bloodmeal. Image credit: who.org. 
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demonstrate mosquito-borne transmission. However, it is still possible that mosquitoes could 
play a role in transmission, and the development of a model to accurately predict this 
phenomenon would require more extensive study. 
Finally, analysis of contaminated insects via PCR, while incredibly sensitive and specific, 
can result in easily misinterpreted data. Our procedure of tandem PCR and culture 
demonstrated that positive PCR signals do not predict the presence of live, transmissible M. 
ulcerans bacilli upon culture. The source of the captured DNA must be considered when 
analyzing PCR results, as DNA from lysed cells and as a part of the M. ulcerans extra-cellular 
matrix may be exceedingly abundant.    
Current studies suggest a limited role for mosquitoes in the transmission of M. ulcerans, 
and perhaps a significant role in environmental maintenance. While the findings of Williamson 
et al (2014) highlight the importance of a puncture-type inoculation for eventual development 
of classical disease, thus the implication of mosquitoes, a wide variety of blood-feeding insects 
have yet to be evaluated. The family Ceratopogonidae contains 4,000 species of blood-feeding 
insects, better known as the biting midge. This family of insects is responsible for the 
transmission of the filarial worm Mansonella and a wide variety of viral pathogens. Additionally, 
pool-feeding insects such as horse flies (family Tabanidae) and black flies (family Simuliidae) are 
aggressive and widely distributed blood-feeding insects responsible for the transmission of 
Trypanosoma, the filarial worm Loa Loa, anthrax, tularemia, and Onchocerciasis (194-198). A 
member of these insect families, with their global distribution and established vector capacity, 









Infection with Mycobacterium ulcerans results in a necrotizing ulceration of the subcutaneous 
tissue and is a major cause of morbidity in more than 30 countries (63). West and Central 
Africa, Australia, and similar tropical localities have reported an increasing incidence of the 
disease over the past decade (199, 200).  Exposure to the bacteria is thought to occur from a 
yet unknown, but persistent, environmental niche. Serological studies of patients in endemic 
areas indicate high sero-prevelence rates compared to disease incidence rates, suggesting that 
exposure to the pathogen without the development of disease is common.  After exposure, and 
over a variable incubation period, infection can progress from a painless nodule, plaque, or 
edema to severe ulceration. It is likely that M. ulcerans persists within a complex food web, 
through the passage and maintenance by various arthropods and mammals within a particular 
ecosystem (201). Recently, other non-human mammals have been discovered to be susceptible 
to infection by M. ulcerans, potentially indicating a diversity of reservoirs used by the bacilli to 
promote persistence in the environment (45). However, the mechanism used to bridge the 
environmental reservoir and susceptible populations has remained elusive, despite numerous 
studies.    
Several insect genera have been investigated for their ability to maintain and transmit 
the pathogen, including mosquitoes (Culex, Anopheles, and Aedes) and biting water bugs 
(Naucoridae, Belostomatidae) (54, 202).  Epidemiological studies have reported strong 
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associations between M. ulcerans and mosquitoes in endemic areas, with Buruli Ulcer patients 
often recalling mosquito bites after visits to endemic areas (61). Thus, a close association with 
insects has been proposed as a potential source of infection (189). Before vector-borne 
transmission was suspected by investigators, it was widely believed that the acid-fast bacilli 
(AFB) could be introduced into a previously existing cut or abrasion and subsequently result in 
Buruli Ulcer (203). This mode of exposure was deemed unlikely in a current study by Williamson 
et al (2014), which demonstrated a lack of pathology associated with M. ulcerans infection 
when abraded guinea pig skin was inoculated with a suspension of M. ulcerans (204). This study 
also suggested that the mechanism of exposure to most likely result in classical Buruli Ulcer 
disease was via injection of the bacteria into the skin, further implicating vector-borne 
transmission.  
Laboratory studies have confirmed M. ulcerans’ ability to colonize many invertebrate 
species. The mechanisms employed by the bacilli to colonize a particular environmental or 
invertebrate niche are not well understood, though it is likely that additional virulence factors, 
not limited to mycolactone, participate in the survival of the bacilli in these varied 
environments. The polyketide toxin mycolactone is the primary virulence factor encoded by M. 
ulcerans. Although it is well known that mycobacteria employ a diverse set of virulence 
determinants promoting their persistence in the environment and the host (205), many of 
which are encoded by M. ulcerans (206).  Indeed, expression of mycolactone is not required for 
colonization in some invertebrate models (52).         
Complex host-pathogen interactions have been thoroughly researched in other models 
of vector-borne diseases, describing intricate host-immune and metabolic disruptions leading 
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to survival and subsequent transmission of pathogens by insects (207). This interaction is 
influenced by the physiology of both the pathogen and the vector, resulting in intertwined 
metabolism. An intriguing and valuable research objective investigating the mechanisms of 
pathogen survival in the host and the dynamics of this interaction have led to innovative 
strategies for vector and pathogen control (53).  
A. gambiae, the infamous malaria vector, is well-known for its ability to transmit a very 
large and complex pathogen (Plasmodium falciparum), and species of the A. gambiae complex 
are distributed throughout geographic locations endemic for Buruli Ulcer disease (190). Some 
of this sympatry has been documented in studies describing M. ulcerans DNA contamination of 
wild-caught mosquitoes from endemic regions and not from non-endemic regions (61, 63). 
Thus, it is highly likely, that due to the abundance and distribution of these two organisms, 
interaction is occurring at some trophic level.   
The objective of this study was to examine the interaction between M. ulcerans and the 
A. gambiae mosquito using untargeted ultra-high-performance liquid-chromatography coupled 
tandem mass spectrometry (UPLC-MS/MS) to identify novel metabolic biomarkers of exposure 
to the pathogen. An untargeted approach in the capture and analysis of metabolites results in 
an unbiased, holistic methodology to generate a metabolic fingerprint associated with a 
specified treatment or exposure. This approach has been used to evaluate metabolic 
perturbations in other pathogenic and nonpathogenic disease states, including cancer, and 
represents an extremely sensitive tool (208). UPLC-MS/MS based metabolomic studies offer the 
most versatility when interrogating a sample set containing molecules of diverse molecular 
characteristics, with the aim to identify and semi-quantify small molecules involved in 
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metabolism (209). Subsequently, identified molecules are mapped to known metabolic 
pathways within an organism to assist in the understanding of biological interactions. To 
evaluate the interaction between these two organisms, A. gambiae larvae were allowed to 
develop in water containing live M. ulcerans, dead (ɣ irradiated) M. ulcerans, or without 
supplemental bacteria. Upon emergence, adult mosquitoes were captured and their metabolic 
patterns were analyzed to investigate pathogen associated effects on development. An 
understanding of the mechanisms employed by the pathogen to promote its survival in the 
mosquito system will ultimately provide significant insight into the persistence of the bacilli in 
the environment and clues towards understanding additional virulence factors utilized by M. 
ulcerans during pathogenesis.  
Materials and Methods 
Bacterial strain and culture 
Mycolactone-negative Mycobacterium ulcerans strain 1615-GFP was kindly provided by 
Dr. Pamela Small from the University of Knoxville, Tennessee. The culture was propagated at 
32°C for a period of 3 weeks on Middlebrook 7H11 (Difco Laboratories, Detroit, MI) plates 
supplemented with Kirschner Selecta-Tabs and 10 µg/ml kanamycin (7H9+), then aliquoted into 
infectivity stocks at a concentration of 1010 cells/ml. Contaminating bacteria from mosquito 
samples were acquired by vortexing the tissues of interest in 7H9+ liquid media, performing a 
10-fold serial dilution and plating the dilutions on Middlebrook 7H11 plates with similar 
antibiotic supplements.  
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Mosquito species and maintenance 
1st-instar larval Anopheles gambiae mosquitoes were acquired from the colony 
maintained at the Arthropod-borne Infectious Disease Laboratory (AIDL) at Colorado State 
University. 100 larval mosquitoes were distributed to individual cages containing 250ml of 
sterile water and supplemented daily with finely ground fish food. All cages were setup in 
duplicate for the individual treatment groups and each experiment was repeated in triplicate. 
Mosquitoes were monitored daily and allowed to develop over a period of 10 days in a 
controlled environment of 28°C and 70% humidity. Mosquito cages were supplemented with 
sterile water and raisins, ad libitum, upon emergence of adult insects. Upon termination of the 
study, adult mosquitoes were aspirated from the cages and briefly knocked down in 4°C. 10 
mosquitoes each were distributed for the generation of technical replicates and their use in 
subsequent assays. 
Invertebrate infections 
100 1st-instar larval mosquitoes were exposed, in duplicate, to live or dead 
supplemental M. ulcerans bacteria, or no supplemental bacteria. 102 cells/ml of live M.ulcerans 
1615-GFP, 102 cells/ml of dead, ɣ-irradiated M. ulcerans 1615-GFP, were added to the sterile 
water upon the addition of larval mosquitoes. All groups received approximately 100mg of fish 
food daily, in addition to the single initial dose of supplemental bacteria. 
Detection of bacteria on mosquito tissues 
A sample of 10 mosquitoes was acquired from each treatment group to determine the 
presence of contaminating M. ulcerans bacilli. Mosquito whole-bodies were collected and 
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assayed for the presence of contaminating M. ulcerans via PCR analysis and culture as 
described (Chapter 4). 
Survival analysis  
The mosquito’s survival to adulthood was measured by counting the number of 
emerged adults and generating a Kaplan-Meier survival curve among the treatment groups, as 
described (Chapter 4). The relative fitness of emerged adults was evaluated by measuring the 
wing size of emerged mosquitoes as a proxy for body size. Both wings were removed and 
measured electronically via the publicly available ImageJ program (imagej.nih.gov/ij/) using a 
line measurement plugin. 
Extraction and purification of small molecules 
5 adult female mosquitoes from each treatment group were collected and immediately 
placed at in 100% methanol at -80°C to preserve their metabolic profile. Frozen mosquitoes 
were then placed in a small Eppendorf tube containing 100ul of cold (-20 degree) 100% 
methanol and homogenized with a handheld eppendorf homogenizer. The suspension was 
briefly centrifuged for 10 minutes at 10,000xg to remove large debris. The supernatant was 
then pushed through a 0.22um filter attached to a 1ml syringe to remove remaining small 
debris. The filtered methanol extract was used for LC-MS/MS analysis.   
Mass Spectrometry 
Acquisition: 1 uL injections of the filtered methanol extract were performed on a Waters 
Acquity UPLC system.  Separation was performed using a Waters Acquity UPLC T3 column (1.8 
µM, 1.0 x 100 mm), using a gradient from solvent A (water, 0.1% formic acid) to solvent B 
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(Acetonitrile, 0.1% formic acid).  Injections were made in 100% A, which was held for 1 min, a 
12 minute linear gradient to 95%B was applied, and held at 95 % B for 3 minutes, returned to 
starting conditions over 0.05 minutes, and allowed to reequilibrate for 3.95 minutes.  Flow rate 
was constant at 200 µL/min for the duration of the run.  The column was held at 50°C, samples 
were held at 5°C. Column eluent was infused into a Waters Xevo G2 Q-Tof MS fitted with an 
electrospray source.  Data was collected in positive ion mode, scanning from 50-1200 at a rate 
of 0.2 seconds per scan, alternating between MS and MSE mode.  Collision energy was set to 6 
V for MS mode, and ramped from 15-30 V for MSE mode. Calibration was performed prior to 
sample analysis via infusion of sodium formate solution, with mass accuracy within 1 ppm. The 
capillary voltage was held at 2200V, the source temp at 150°C, and the desolvation 
temperature at 350°C at a nitrogen desolvation gas flow rate of 800 L/hr. 
Processing: XCMS peak detection was performed on both the low and high collision energy 
channels (MS and MSe).  The datasets were separated following alignment, and the idMS/MS 
workflow described previously was applied for generation of indiscriminant MS/MS spectra for 
library searching and compound identification (210). 
Statistical analysis  
All data collected were subjected to principle component analysis (PCA) for dimensional 
reduction, linear transformation, and consolidation of variables before any labelling. All 
idMS/MS spectra were analyzed by two-way ANOVA (P≤0.05 considered significant) to generate 
a dataset containing only compounds that demonstrated statistically significant abundance 
among all treatment groups. From this dataset, the abundance of individual compounds 
between treatments were compared using a two-sided student’s t-test (p≤0.05) to generate a 
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dataset containing compounds dually significant by both ANOVA and t-test. These dually 
significant compounds were then subjected to library searching for identification.  
Library searching and compound identification 
MS/MS spectra from dually significant compounds were compared against in-house 
small molecule libraries developed and validated by the Proteomics and Metabolomics Core 
facility (PMF) at Colorado State University, the Metlin Mass Spectral database, and NISTv12 for 
identification via spectral matching and retention time data.  Annotation confidence levels as 
recommended by the Metabolites Standards Initiative were applied (211). Briefly, samples were 
initially compared against the PMF validated chemical reference library. A compound was 
identified with level I confidence upon matching the mass spectra, retention time, and m/z of 
the chemical reference standard validated with identical instrumental conditions. Compounds 
annotated with level II confidence are based upon similarity of mass spectra, exact mass, and 
m/z of the putative compound with the commercialized Metlin database and NISTv12. Level III 
identification was based on similarity of the mass spectra of putative compounds to known 
compounds in a chemical class. Unknown compounds, which were still differentiated and 
quantified using the techniques described, contain unique chromatographic features and are 
reported as "unknown.” 
Results and Discussion 
Time course of mosquito exposure and survival  
100-1st instar A. gambiae larvae were distributed into cages in duplicate. Upon 
initiation, groups receiving supplemental bacteria (live M. ulcerans or ɣ-irradiated M. ulcerans) 
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were dosed. Treatment groups received a single dose of supplemental bacteria at initiation of 
the experiment, then received ground fish food daily. Mosquitoes were allowed to develop 
over a period of 10 days until they emerged as adults. During this time course, survival of the 
mosquitoes were measured via daily counts of larvae. Upon emergence, the number of 
mosquitoes which survived to adulthood were counted to evaluate survival over the duration of 
development (Chapter 4).  Briefly, mosquitoes exposed to live M. ulcerans were found to have 
reduced survival and fitness by adulthood, compared to the control groups (Figure 23).  
 
Composition and analysis of methanol extracts of mosquito after exposure to M. ulcerans 
A sample of 15 adult female mosquitoes was collected from each treatment group and 
divided into replicates of 5 adult mosquitoes per sample. After homogenization in cold 
methanol and filtration, the samples were subjected to UPLC-MS/MS for semi-quantitative 
global detection of metabolites. The preservation of the metabolite profile is paramount in any 
metabolomics study, hence the use of rapid freezing and methanol quenching. Metabolite 
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Figure 23: Summary of mosquito survival (left) and size (right) from Chapter 4. Mosquitoes exposed to live M. 
ulcerans are significantly smaller than controls and have reduced survival to adulthood. ***=p<0.001. 
75 
 
extraction procedures can significantly 
influence the quality and composition 
of metabolites in a study, leading to a 
biased analysis of the biological 
significance of small molecules (212).     
Multivariate analysis (PCA) of the 
metabolite data demonstrates distinct 
separation of metabolic profiles 
among treatment groups (Figure 24). 
Treatment groups are well separated 
whereas replicates within each 
treatment are closely clustered.  Clustering of compounds based on similar retention times and 
abundance reduces background and 
streamlines analysis of significant compounds. 
Bubble plots of metabolites from this 
experiment reveal the sheer number of small 
molecules captured and clusters of significant 
features (Figure 25). The cluster highlighted in 
Figure 25 represents a significant cluster of 
lipids via differential analysis. After data 
reduction and clustering, a list of 134 
compounds were found to have statistically 
Figure 24: PCA plot of untargeted metabolite analysis 
demonstrates significant clustering of compounds based on 
exposure. Control group in black (upper right); dead M. 
ulcerans group in red (bottom left); and live M. ulcerans 
group in green (top left).    
Figure 25: Bubble plot of total metabolite demonstrates 
spectral clustering of compounds for all treatment 
groups. Line separating chart represents P<0.05 cutoff 
for significance. Oval highlighting significant cluster of 
features as a function of retention time.  
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significant differences in abundance among treatment groups. From this list, 25 were identified 
with level I confidence (211) (Table 2).  A significant number of compounds were not 
identifiable with Level I confidence (Table 2). This may be due to a lack of coverage of 
Anopheles-specific metabolites in spectral libraries. Representative head-to-tail plots of 
selected compounds are shown in appendix I and the total ion chromatogram of treatment 
groups is shown in figure 26. While metabolomics is quickly becoming a valuable tool for global 
assessment of exposure-induced metabolic effects, the confident identification of small 
molecules and the assignment of biological significance represents a bottleneck in the analyses 
of these studies (212). The expansion of spectral libraries and the availability of open-source 




















































































































Figure 26: Total ion chromatograms (TIC) by treatment group. A: TIC of control mosquitoes. B: TIC of mosquito 
exposure to dead M. tuberculosis. C: TIC of mosquitoes exposed to live M. ulcerans. D: TIC of mosquitoes 







Table 2: Dually significant compounds  
 
         









C589 unknown n/a 521.3 440.277 0.003 IV 4.150 2.810 
C341 unknown n/a 484.9 199.133 <0.001 IV 3.450 2.390 
C828 Orotic acid-like C00295 781.3 297.279 0.010 III 3.392 0.536 
C724 1-oleoyl-2-palmitoyl-sn-glycero-3-PC 18:1/16:0 C04317 759.8 760.597 0.010 I 2.754 0.896 
C814 GPEtn 42:3 C04475 858.6 804.557 0.040 III 2.753 0.483 
C355 GPEtn (20:0/20:0) C04475 737.7 782.579 <0.01 III 2.438 1.067 
C753 unknown n/a 792.7 738.627 0.003 IV 2.346 1.181 
C321 unknown n/a 583.6 510.356 0.010 IV 2.320 1.590 
C209 unknown n/a 807.7 826.541 0.016 IV 2.260 0.755 
C426 Lyso-PC 24:0 C04317 575.7 570.355 0.004 III 2.215 1.114 
C506 unknown n/a 792.0 800.528 0.045 IV 2.199 0.765 
C591 unknown n/a 560.4 307.227 0.001 IV 2.110 1.800 
C686 GPEtn 42:3 C04475 720.4 804.579 <0.001 III 2.002 1.070 
C78 unknown n/a 650.0 309.243 0.006 IV 1.917 0.851 
C295 riboflavin C00255 229.1 377.146 0.010 I 1.879 1.287 
C456 peptide fragment n/a 556.4 546.284 0.005 III 1.874 0.807 
C643 unknown n/a 772.2 760.593 0.030 IV 1.860 0.985 
C465 oxytocin-like C00746 550.0 955.584 0.012 III 1.851 0.970 
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C24 Dodecylbenzenesulfonic acid n/a 752.6 554.177 <0.01 III 1.830 1.050 
C493 Sphingomyelin 40:5 C00550 825.5 786.509 0.027 III 1.759 0.806 
C737 GPEtn(18:3(6Z,9Z,12Z)/ 18:3(6Z,9Z,12Z)) C04475 829.8 737.539 0.050 I 1.726 1.776 
C795 unknown n/a 589.5 1001.670 0.008 IV 1.688 2.027 
C482 unknown n/a 734.1 331.263 0.005 IV 1.661 1.006 
C186 1-hexadecanoyl-sn-glycero-3-PC C04317 522.7 518.325 0.030 II 1.660 0.740 
C443 unknown n/a 530.8 522.379 0.002 IV 1.600 0.750 
C555 dynorphin-like C01574 646.2 508.341 0.006 III 1.592 1.306 
C187 unknown n/a 517.5 452.277 <0.001 IV 1.570 1.050 
C703 unknown n/a 522.9 544.268 0.009 IV 1.560 1.011 
C338 unknown n/a 549.4 509.345 <0.01 IV 1.560 1.490 
C326 GPEtn(7:0/20:4(5E,8E,11E,14E)) C04475 513.6 472.364 0.020 III 1.550 1.415 
C52 Lyso-PC 16:0 C05209 520.0 476.279 0.034 III 1.523 0.850 
C750 unknown n/a 763.6 684.581 <0.001 IV 1.449 1.311 
C217 Sphingomyelin (d19:1(4E)/26:1(17Z)) C00550 948.0 85.086 0.020 III 1.420 1.220 
C240 Lyso-PC 18:0 C04317 618.5 524.372 0.030 III 1.400 0.978 
C379 unknown n/a 774.7 712.611 0.020 IV 1.394 0.850 
C71 GPSer (15:0/25:0) C18125 768.1 761.609 0.004 III 1.380 0.920 
C67 1-oleoyl-2-hydroxy-sn-glycero-3-PC 18:1 C04317 546.1 544.340 0.010 I 1.359 0.681 
C449 ACTH-like C02017 508.4 468.309 <0.01 II 1.356 1.410 
C442 unknown n/a 536.3 544.341 0.001 IV 1.353 0.921 
C183 Lyso-PE 18:1 C05209 586.4 959.613 0.020 III 1.350 1.570 
C390 unknown n/a 916.8 804.556 0.015 IV 1.326 0.922 
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C575 ACTH-like C02017 587.9 587.940 0.033 III 1.309 1.780 
C243 2-oleoyl glycerol n/a 595.1 542.299 0.020 III 1.300 1.080 
C344 ACTH-like C02017 500.0 468.308 0.017 III 1.290 1.285 
C461 unknown n/a 540.6 498.379 0.038 IV 1.259 0.837 
C32 GPCho(16:0/16:1(7Z)) C00157 530.5 494.324 <0.01 I 1.241 1.818 
C35 1-palmitoyl-2-hydroxy-sn-glycero-3-PC 16:0 C04317 571.6 496.340 0.010 I 1.237 1.192 
C83 GPEtn (5:0/24:4(5Z,8Z,11Z,14Z) C04475 558.3 500.395 0.027 III 1.234 0.986 
C335 GPEtn(9:0/18:3(6Z,9Z,12Z)) C04475 545.1 474.379 0.030 III 1.230 0.856 
C245 peptide fragment n/a 528.1 452.277 <0.001 III 1.220 1.930 
C799 phenytoin, 1.5,5-Diphenylhydantoin C07443 528.1 253.100 <0.01 II 1.217 1.958 
C444 Lyso-PE 29:5 C05209 530.0 498.379 0.018 III 1.212 0.692 
C562 Lyso-PE 20:4 C05209 574.1 361.274 0.014 III 1.202 0.395 
C195 unknown n/a 548.1 466.293 0.020 IV 1.200 2.160 
C560 angiotensin-like C15850 578.8 1031.713 0.010 III 1.197 1.376 
C328 unknown n/a 520.2 516.306 <0.01 IV 1.180 1.600 
C107 neurotensin-like n/a 552.3 502.294 0.040 III 1.150 0.890 
C29 1-oleoyl-2-hydroxy-sn-glycero-3-PC 18:1 C04317 589.4 522.356 <0.01 I 1.150 1.332 
C512 TG 61:5; [M+Na]+; TG(19:0/20:5/22:0) C00422 1001.0 703.575 <0.01 I 1.148 0.583 
C194 Lyso-PE C05209 543.5 502.294 0.050 III 1.140 0.840 




C01233 586.4 480.309 <0.01 I 1.117 1.267 
C104 GPCHo (17:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)) C05212 520.3 494.324 <0.01 II 1.100 1.400 
C581 choline C00114 526.9 564.307 0.010 I 1.099 1.759 
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C123 Lyso-PE 16:1 C05209 536.0 311.259 <0.01 III 1.090 1.800 
C705 unknown n/a 520.3 517.311 0.018 IV 1.087 1.410 
C80 1-oleoyl-2-hydroxy-sn-glycero-3-PC 18:1 C04317 578.6 522.356 0.020 I 1.074 1.118 
C315 iosprene unit n/a 575.6 975.633 0.014 III 1.070 1.165 
C807 unknown n/a 520.2 1014.612 0.010 IV 1.069 1.773 
C711 unknown n/a 546.1 299.132 0.045 IV 1.065 0.799 
C590 Lyso-PC 20:1 C04317 520.3 266.639 0.008 III 1.060 1.360 
C790 GPEtn 28:6 C04475 574.1 621.303 0.008 III 1.057 0.512 
C712 adrenosterone-like C05285 546.2 582.300 0.011 III 1.016 0.749 
C810 1-heptadecanoyl-2-hydroxy-sn-glycero-3-PC 17:0 C04317 556.7 473.272 0.030 I 1.002 1.208 
C422 unknown n/a 633.1 283.263 <0.001 IV 0.999 2.127 
C22 Lyso-PE 16:1 C05209 517.6 474.260 <0.01 III 0.980 1.610 
C96 8,11,14-Eicosatrienoic acid C03242 705.1 305.248 <0.01 I 0.974 0.684 
C550 unknown n/a 708.6 179.143 0.028 IV 0.971 0.819 
C401 adenosine C00212 98.1 141.959 <0.01 I 0.966 0.642 
C120 1-octadecanoyl-sn-glycero-3-PE C04475 623.8 482.324 0.017 III 0.964 0.856 
C818 unknown n/a 728.8 308.265 0.011 IV 0.952 0.692 
C223 Lyso-PE 21:0 C05209 264.2 520.338 0.050 III 0.951 1.122 
C205 Oleic acid-like C00712 749.0 283.264 0.044 III 0.943 0.851 
C800 1-tetradecanoyl-sn-glycero-3-PC 14:0 C04317 517.6 253.603 0.030 I 0.934 1.375 
C709 unknown n/a 539.7 743.395 0.026 IV 0.923 0.770 
C203 GPEtn(17:1(9Z)/17:1(9Z)) C04475 749.1 689.561 0.022 III 0.922 0.589 
C95 1-octadecanoyl-sn-glycero-3-PE C04475 716.0 357.300 0.031 III 0.921 0.642 
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C577 unknown n/a 536.3 571.290 0.015 IV 0.910 1.529 
C118 unknown n/a 704.2 235.169 0.010 IV 0.900 0.600 
C447 unknown n/a 525.6 299.628 0.011 IV 0.885 0.744 
C234 unknown C11045 708.9 281.248 <0.01 III 0.880 0.830 
C179 20-Hydroxy-(5Z,8Z,11Z,14Z)-eicosatetraenoic acid C14748 559.8 303.232 0.010 I 0.877 0.904 
C180 prostaglandin-like C00639 697.3 329.248 <0.01 III 0.870 0.670 
C408 GPEtn (20:0/18:2) C04475 670.1 379.283 0.001 III 0.867 0.586 
C787 8,11,14-Eicosatrienoic acid C03242 694.6 305.248 0.030 I 0.856 0.629 
C583 unknown n/a 516.7 298.626 0.010 IV 0.850 0.539 
C688 pimelic acid-like C02656 708.8 245.227 0.001 III 0.850 0.781 




n/a 708.6 239.202 0.040 III 0.829 0.809 
C178 unknown n/a 669.9 171.122 0.020 IV 0.828 0.753 
C568 unknown n/a 568.3 318.131 0.037 IV 0.825 0.730 
C416 GPEtn(15:0/18:2(2E,4E)) C04475 708.7 264.241 0.010 III 0.820 0.799 
C415 3-cyclohexyl-1-propanol n/a 708.8 83.086 0.019 III 0.818 0.809 
C93 Androstane-like C03772 669.9 267.212 0.004 III 0.806 0.836 
C430 unknown n/a 568.6 279.232 0.017 IV 0.798 0.846 
C663 unknown n/a 946.6 304.299 0.017 IV 0.797 1.120 
C322 peptide fragment n/a 534.3 641.271 0.035 III 0.796 0.907 
C366 unknown n/a 825.0 529.881 <0.001 IV 0.783 0.958 
C704 unknown n/a 523.3 270.120 0.006 IV 0.760 0.851 
C808 1-hexadecanoyl-sn-glycero-3-PC 16:0 C04317 559.7 478.327 <0.01 I 0.752 1.125 
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Table 2 key:  
a) In house clustered feature identifier. b) identification of compound based on match of mass spectra, m/z ratio, and/or retention time to available 
databases. c) compound identifier from Kyoto Encyclopedia of Genes and Genomes (www.genome.jp/kegg/) d) generated via liquid chromatography. e) 
mass to charge ratio of the largest peak from the mass spectra. f) level of significance of pairwise comparison between treatment and controls groups. g) 
confidence level of identification based on matching of chromatographic and mass spectral characteristics for each compound to validated compound 
library or publicly available databases, from Sumner et al. 2007. Metabolomics. h/i) fold change in abundance of compound compared between control 
and treatment groups.  Abbreviations: PC: phosphocholine; GPCho: glycerophosphocholine; GPEtn: glycerophosphoethanolamine; GPSer: 
glycerophosphoserine; ACTH: adrenocorticotropic hormone; X:N represents number of carbons to double bonds in a given compound.  
C227 Deoxyadenosine monophosphate C00360 360.3 98.512 <0.01 III 0.743 0.770 
C38 histamine-like C00388 990.5 130.159 0.048 III 0.730 0.694 
C102 Lyso-PE 16:0 C05209 528.0 245.616 0.020 III 0.730 1.600 
C548 unknown n/a 708.5 139.112 0.001 IV 0.727 0.663 
C177 Deoxyadenosine monophosphate C00360 356.4 98.512 0.030 III 0.710 0.790 
C151 Lyso-PC 20:0 C04317 646.5 468.345 0.017 III 0.710 0.790 
C336 Lyso-PE 17:1 C05209 549.6 506.323 <0.01 III 0.680 0.391 
C593 unknown n/a 554.9 530.320 0.007 IV 0.670 0.279 
C421 GPCho (14:0/17:1(9Z)) C05212 598.9 508.339 <0.001 III 0.654 0.213 
C100 GPCho (17:1(9Z)/22:5(4Z,7Z,10Z,16Z)) C05212 586.2 508.340 <0.01 II 0.600 0.170 
C641 Dodecylbenzenesulfonic acid n/a 849.2 703.217 <0.01 II 0.524 0.482 
C578 unknown n/a 534.3 424.324 0.011 IV 0.488 0.275 
C766 trans-8, trans-10-Dodecadien-1-ol C02679 1031.0 141.959 <0.001 I 0.467 0.579 
C528 unknown n/a 24.6 173.021 <0.001 IV 0.463 0.784 
C699 unknown n/a 517.6 398.327 0.033 IV 0.454 0.485 
C349 trans-8, trans-10-Dodecadien-1-ol C02679 1074.8 141.959 0.020 I 0.369 0.398 
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Phospholipid pathways affected by exposure to M. ulcerans 
An analysis of the metabolites of contrasting abundance among treatment groups was 
analyzed in an attempt to correlate the disruption of metabolic pathways with the reduced 
survival and fitness described in the adult mosquitoes (Chapter 4 and Figure 23). Of the 
identified compounds with significantly different regulation among treatments, the vast 
majority belong to the lipid metabolism functional group. The primary metabolites showing the 
most significant fold change in abundance among treatments belong to the phospholipid and 
ether lipid class of molecules, comprising the main components of biological membranes (213). 
In particular, diacylated glycerophosphocholine (PC) 
molecules were found to be in abundance in live M. 
ulcerans exposure groups (Table 2). While this class 
of molecules is ubiquitous in membranes, the high 
levels of these molecules in mosquitoes exposed to 
live M. ulcerans compared to other groups, may 
indicate an impaired mechanism of PC hydrolysis 
occurring in live-pathogen exposed groups. 
Specifically, the accumulation of 1-oleoyl-2-
palmitoyl-PC in live M. ulcerans groups compared to 
both the control and dead M. ulcerans groups suggests a mechanism of live-pathogen induced 
disruption of utilization or disruption of the mosquito’s membrane integrity during exposure 
(Figure 27).  
Figure 27: Box and whisker plots of the 
abundance of 1-oleoyl-2-palmitoyl-PC 
(top)(C724) and 1-oleoyl-2-hydroxy-PC 
(bottom)(C67) compared to other treatment 
groups. CTRL:control; Mu-:irradiated M. 





Accumulation of lyso-phosphatidylcholine compounds (LysoPC) (monoacylated 
glycerophosphocholine) occurs primarily in mosquitoes exposed to dead M. ulcerans compared 
to both the control and live M. ulcerans treatment groups. Hydrolysis of the PC molecule 
resulting in the formation of 2-LysoPC is the result of cleavage of the sn-2 acyl bond potentially 
by a putative Anopheles encoded phospholipase A2 (UniProt: T1EAP2_ANOAQ) or via enzyme 
secretion from commensal microbiota assisting in digestion, and represents the most abundant 
LysoPC in nature (214). This finding suggests that mosquitoes exposed to live pathogen, thus 
resulting in low abundance of 2-LysoPC compared to controls, may have impaired transcription 
and regulatory functions as a result (214) (Figure 28).  
 
Glycerophospholipid metabolism in Anopheles mosquitoes is a critical component of 
metabolism utilized for the generation of lipid energy sources, components of cell membranes, 
and signaling pathway modulators (215). Mosquitoes rely on a lipid carrier protein, lipophorin, 
as a reusable shuttle for the transportation of lipid molecules from sites of storage or synthesis 
to sites of utilization as an energy source or as precursors to triacylglycerol and phospholipid 
Figure 28: Box and whisker plots of the abundance of 2-LysoPC compounds detected in mosquito tissues. C808 
represents the abundance of 1-hexadecanoyl-LysoPC 16:0 (left) and C800 represents the abundance of 1-
tetradecanoyl-sn-glycero-3-LysoPC 14:0 (right) in mosquitoes exposed to irradiated M. ulcerans (Mu-) in 




synthesis. In contrast with other eukaryotic organisms which store lipids as mixtures of mono-, 
di-, and triglycerides, triacylglycerides (TG) are the major component of mosquito lipid storage 
and may be cleaved to release fatty acids as an energy source (215). In our model, TG was 
found to have significantly higher abundance in mosquitoes exposed to live M. ulcerans, 
perhaps suggesting some mechanism of pathogen induced disruption of the utilization of this 
molecule. In contrast, mosquitoes exposed to dead M. ulcerans, had lower abundance of TG 
than control mosquitoes (Figure 29), suggesting a reduced requirement for TG accumulation, or 
a greater utilization of the molecule 
when provided a lipid-rich mycobacterial 
diet resulting in increased survival and 
size compared to control mosquitoes 
(Chapter 4 and Figure 23). An abundance 
of unsaturated fatty acids and 
glycerophospholipds in mosquitoes is 
thought to be an adaptation to an 
aquatic environment (216), and the 
composition and distribution of these 
molecules in insect’s tissues has also been 
shown to differ with diet (217) (Figure 30).  
 
Figure 29: Abundance of Compound 512 
(triacylglyceride-TG) in treatment groups. Mosquitoes 
exposed to dead M. ulcerans have significantly lower 
abundance of TG than control while mosquitoes 
exposed to live M. ulcerans have significantly higher 





Figure 30: Phospholipids (PL) are a major constituent of biological membranes. PL are characterized by a 
glycerol backbone attached to a phosphodiester group and a polar head group. Phosphatidylcholine (PC) is a 
functional class of PL molecule characterized by a choline head group. The fatty acid composition of PC can 
vary, but is generally composed of one saturated fatty acid and one unsaturated fatty acid, attached in the R 
position (A). Phospholipase hydrolysis of the PC molecule results in a plethora of subunits involved in many 
downstream signaling and metabolic processes (B). As PC molecules are cleaved by phospholipase A/B/C/D 
(Pla/b/c/d), fatty acids are released (C), in addition to other cleavage products such as diacylglycerol (DAG), 
phosphatidic acid (PA), and choline (D).  Fatty acids liberated from PC, DAG, TG, LysoPC can be elongated 
and/or modified to form ubiquitous signaling molecules. In this study, eicosatrienoic acid and 20-hydroxy 
eicosatetraenoic acid (hydroxy arachidonic acid) were found to be in lower abundance in groups exposed to M. 








Disruption of host-lipid metabolism is a well-characterized feature of many 
mycobacterial infections, in addition to an increasing number of intra- and extracellular 
pathogens including Clostridium perfringens, Corynebacterium pseudotuberculosis, 
Pseudomonas aeruginosa, Staphylococcus aureus, Listeria moncytogenes, M. leprae, and M. 
avium (218). Additionally, histopathological analysis of mouse footpad tissues revealed the 
presence of foamy macrophages during late M. ulcerans infection (Chapter 3: Figure 10D, 
Figure 13). During active and chronic infection with M. tuberculosis, the accumulation of TG-rich 
lipid bodies in foamy macrophages is used as an energy source for the intracellular pathogen 
(219). The development of P. falciparum in infected mosquitoes is also associated with 
disruption of host lipid metabolic pathways, thus our findings seem consistent with 
mechanisms employed by other pathogens for survival in the mosquito (220). The discovery of 
the high abundance of TG in mosquitoes contaminated by live M. ulcerans, but not dead M. 
ulcerans, is consistent with these reports and has not yet been described in the mosquito 
system. 
Hormone-like compounds 
Secondary metabolites of the lipid metabolic pathways are involved in immune signaling 
in both vertebrates and invertebrates. Hormones are used to signal the generation and 
utilization of these lipid mediators. An analog of the ACTH-releasing molecule (corticotropin-
releasing factor, CRF) has been discovered in mosquitoes (221), and ACTH-like molecules are 
present in insect cells with phagocytic activity (222). This molecule functions as a stress 
response hormone involved in immune cell chemo-attraction, phagocytosis, and capsule 
formation, factors of the primary immune response in most insects (223).  Counterparts of the 
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full vertebrate CRF-ACTH endocrine system have not 
yet been described in Anopheles systems, although 
analogs of these compounds in insects may 
represent evolutionary precursors to the vertebrate 
systems (221). An ACTH-like compound was found 
to be in high abundance in both mosquito groups 
exposed to M. ulcerans bacteria compared to the 
control group (Figure 31). A high abundance of this 
molecule in both groups of mosquito exposed to M. 
ulcerans suggests the initiation of an immunological or 
neurological response to the presence of the mycobacteria. The neuroendocrine system is a 
highly complex network of metabolic pathways and endocrine activity, thus, speculation 
regarding the effects of differentially regulated compounds within this system must be taken 
with caution. 
In vertebrate systems, hormones such as ACTH stimulate arachidonate release, which 
can then be converted into eicosanoid compounds such as prostiglandins and lipoxygenase 
metabolites (224). Eicosanoids are oxygenated metabolites of polyunsaturated fatty acids and 
are potent signaling molecules involved in inflammation, immunity and the nervous system of 
vertebrates, invertebrates, and many eukaryotic microbes (225). Interestingly, suppression of 
eicosanoid synthesis within the host is a major mechanism utilized by entomopathogenic 
bacteria during infection and during protozoan development in anopheles mosquitoes (226, 
227). These findings suggest that modulation of eicosanoid signaling by pathogenic 
Figure 31: Abundance of C449, an 
adrenocorticotropin hormone (ACTH)-like 
molecule found to be in high abundance 
in mosquitoes exposed to both live and 




contaminants of invertebrate systems facilitates survival of these pathogens. In line with this, 
mosquitoes in our model of M. ulcerans infection were found to have significantly lower 
abundance of the eicosanoids 8,11,14-Eicosatrienoic acid and 20-Hydroxy-(5Z,8Z,11Z,14Z)- 
eicosatetraenoic acid (20-HETE) (Figure 32), and may represent a rudimentary mechanism of 








Figure 32: Abundance of eicosanoid compounds in mosquitoes exposed to live (Mu+) and dead (Mu-) M. 
ulcerans bacteria compared to control mosquitoes. Eicosanoids are mediators of a wide variety of immune 
signaling processes, and the down regulation of these compounds is suspected to increase the survival of 
contaminating pathogens. C179 (left) represents the abundance of 20-HETE and C787 (right) represents the 
abundance of Eicosatrienoic acid.  
20-HETE Eicosatrienoic acid 
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Fatty acid mediators and signaling 
Many effects of eicosanoid modulation are not well known insect systems, although a 
decreased abundance of these compounds may be due to the active modulation by M. ulcerans 
or due host immune non-recognition of the pathogen, therefore leading to the depressed 
function of a non-necessary system.  For example, the compound 20-HETE, a metabolite of 
arachidonic acid, is involved in the detoxification response via the cytochrome P450 system 
(228). Lower abundance of the 20-HETE lipid mediator may result in reduced capacity of the 
P450 system to generate reactive oxygen species in an effort to combat the contaminating M. 
ulcerans bacilli.   
Secondary metabolites 
In addition to the various perturbations of lipid metabolic pathways discovered in this 
study, the abundance of other compounds are deserving of mention. However, the analysis of 
their role in our model of infection is undertaken with restraint due to the lack of available 
information regarding the dynamics of these molecules in the anopheles mosquito. Insects use 
a variety of pheromones during reproduction and host-seeking behavior. The codling moth 
(Cydia pomonella) produces dodecadienol as a precursor in the synthesis of a sex hormone 
(229). Although the presence of this compound is not yet described in mosquito systems, the 
significantly reduced abundance of 8-10-dodecadienol in mosquitoes exposed to both live and 
dead M. ulcerans in our model may be a marker of reduced fecundity. However, mosquitoes 
exposed to dead M. ulcerans bacilli have higher survival rates compared to control mosquitoes, 
in concert with low abundance of the putative pheromone, thus contradicting this finding.  
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Riboflavin is an essential B vitamin in nearly all pro- and eukaryotic organisms, serving as 
a precursor for the synthesis of flavin coenzymes and flavin adenine dinucleotide which are 
essential cofactors for a wide variety of metabolic enzymes and electron transport (230). This 
molecule was found to be significantly upregulated in 
mosquitoes exposed to live M. ulcerans compared to 
both control mosquitoes and mosquitoes exposed to 
dead M. ulcerans. In addition to metabolic processes, 
riboflavin is also involved in areas of yellow 
pigmentation, such as the eyes and malpighian tubules 
(231). The accumulation of riboflavin in mosquitoes 
exposed to live M. ulcerans, and the less extreme 
accumulation in mosquitoes exposed dead M. ulcerans 
is surprising. Mycobacterium smegmatis and the 
closely related Corynebacterium diptheriae is considered to be overproducers of riboflavin 
(230). The proteins involved in riboflavin synthesis and processing have been documented in 
the M. ulcerans proteome (NCBI accession: WP_011740179 (riboflavin kinase) and 
WP_011740778 (riboflavin biosynthesis protein)). The dynamics of riboflavin metabolism are 
not specifically defined in M. ulcerans, however a flavin analog (F420-dependent reductase) is 
synthesized using a riboflavin precursor and is involved in the degradation of aflatoxins (232). 
The accumulation of riboflavin in our model may be due to an overproduction of the molecule 
by contaminating bacilli, or a disrupted mechanism of metabolism of the molecule in the 
mosquito due to M. ulcerans exposure (Figure 32). It has also been suggested that an 
Figure 32: Box and whisker plot showing the 
abundance of riboflavin in treatment groups. 
Mosquitoes exposed to live M. ulcerans 
(Mu+) show a significant accumulation of 
riboflavin compared to the other groups 




overproduction or supplementation of riboflavin may help to control the development of P. 
falciparum in the mosquito (233).  
The compounds identified in our model and the putative assignment of biological 
significance thereof may represent the cumulative effects of virulence mechanisms employed 
by M. ulcerans during contamination of mosquitoes. Many of the features describing disrupted 
metabolism in the mosquito due to exposure to M. ulcerans are novel, although they are based 
on analogous mechanisms from many similar interactions. While many of the disrupted 
pathways described here have been documented to be affected by other mycobacterial 
pathogens in other systems, an metabolic investigation of the host-pathogen dynamics 
between A. gambiae and M. ulcerans how not been done before and will contribute significant 
evidence towards the understanding of additional virulence mechanisms employed by M. 
ulcerans. This study is the initiation of not only a better understanding of M. ulcerans metabolic 
interaction with A. gambiae, but can be generalized as a complex in vitro model of M. ulcerans 
pathogenesis.  Metabolism is inherently temporal and spatial, so continued analysis of this 
interaction must include additional or repeated measures for a more complete understanding. 
Representative head-to-tail plots are displayed in appendix I, including some compounds that 










In comparison to other notable mycobacterial diseases, Buruli Ulcer disease has a 
proportionally small impact on global health. Lack of surveillance and health care resources in 
the exceedingly rural environment of endemic regions complicates the accurate measure of 
disease burden. Some estimates report between 5,000-7,000 new cases per year, with nearly 
half of those originating from just Cote d’Iviore (234).  M. ulcerans infection has a major impact 
on the individual however, evidenced by estimates that 66% of people with healed lesions had 
some degree of permanent physical disability (235). The median age of patients in the 
aforementioned study was only 12 years old. In fact, nearly 50% of patients affected by Buruli 
Ulcer disease are under the age of 15 (236). This predilection of infection in children is one of 
the most unfortunate aspects of Buruli Ulcer disease. A better understanding of this 
phenomenon will likely involve investigation from a variety of different approaches, including 
an analysis of the effects of environmental disruption, availability nutritional resources, and 
climate change.      
Our understanding of the basic mechanisms surrounding the survival and maintenance 
of the bacterium in the environment, coupled with a lack of knowledge regarding transmission 
of the pathogen and subsequent pathogenic features of infection is evidenced by the increasing 
incidence and prevalence of the disease. Recently, the condition has been reported or 
suspected in more than 33 countries and the number of reported cases is growing (237). West 
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and central Africa bears the brunt of M. ulcerans infection, similar to other neglected tropical 
diseases, while other important foci are found in Australia, French Guiana, Peru, and Papua 
New Guinea (200, 238, 239). Recently, reports of M. ulcerans infection have spread to Japan 
(240). No confirmed infections have been documented in the United States, although evidence 
of M. ulcerans contamination of marsh lands in Louisiana brings the potential for infection close 
to home (241).   
The value and application of animal models of Buruli Ulcer can be appreciated by the 
recent shift in treatment protocols. Historically, extensive surgery left Buruli Ulcer patients with 
massive, debilitating scars, not unlike those from unmanaged infection. The extensive use of 
animal models to assess different treatment modalities has resulted in a better understanding 
of the host immune response to M. ulcerans and the deployment of an effective antibiotic 
regimen (242).  These advances have resulted in reduced severity of cases than what was seen 
a decade ago (15). The mouse model presented in Chapter 3 is the first to describe a 
mycolactone-negative infection in immunocompetent and immunodeficient mice resulting in 
immunosuppression. The strain used in the study is considered attenuated due to the lack of 
mycolactone expression, although it is clear that many pathogenic features common to 
infection with M. ulcerans are still retained. The analysis of the cytokine concentrations in 
mouse tissues confirms the extent of immune suppression, resulting in a significant decrease in 
the concentrations of protective IFN-ɣ in conjunction with an increase in pathology of the 
footpad. Additionally, the abundance of cytokines IL-6 and IL-12 in both early and late infection 
may serve as markers for the disease, as the presence of these cytokines has been documented 
in other studies (142). However, due to lack of experimental data, the variability of cytokine 
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expression due to host and environmental factors resulting in a specific presentation or 
prognosis as not been substantiated. Further clinical studies will help to refine the extent that 
host-factors influence pathogenesis.   
Currently, the route of transmission and mechanism of environmental persistence is 
unknown. As such, a throng of researchers have published dozens of papers regarding putative 
modes of transmission or environmental niches for the bacteria, including research found in 
this dissertation. Despite the intensity of research into these areas, many aspects of M. ulcerans 
pathobiology remain elusive. Ulceration most often occurs on the limbs or extremities of 
patients and, in one documented instance, on a child’s ear (63). This feature led many to 
suspect vector-borne transmission of the disease. Since the early 1999, many groups have 
investigated the role of aquatic insects in transmission, with varying results. Two reports stand 
out among many: the first cultivation of M. ulcerans from an aquatic insect (14) and the 
transmission of M. ulcerans by a biting water bug (60). In the first study mentioned, M. ulcerans 
was cultured from a water strider (Gerris sp.), thus establishing the role of aquatic insects in the 
maintenance of the bacilli in the wild. The second study was the first to describe transmission 
via aquatic insect to a mouse through contaminated raptorial arms. Unfortunately, the insect 
used in this study (Naucoridae sp.) is not hematophagous and does not associate with humans. 
Other studies have described a strong association between M. ulcerans and mosquitoes of 
many genera. As of yet, no study has been able to document mosquito-borne transmission of 
the bacilli, although many still suspect this route to be likely. Transmission via puncture wound 
as a result of a mosquito bite containing active M. ulcerans in the context of 
immunomodulatory mosquito saliva remains an attractive hypothesis.  Additional studies using 
97 
 
more thorough microbiological methods for detection of active M. ulcerans bacilli in and on 
mosquito tissues, beyond PCR, is greatly needed. Unfortunately, endemic regions of Buruli 
Ulcer disease are not conducive to the application of intricate scientific methods. Despite 
evidence presented here (Chapter 4 and 5), that mosquitoes represent an unlikely vector of M. 
ulcerans, in addition to a recent study with corroborating conclusions (161), the well 
documented sympatry between the pathogen and mosquitoes highlights the need for 
continued study into the extent of association between these two organisms.  
 There exists a major discrepancy between two primary areas of research into the 
biology of M. ulcerans. The discrepancy lies in the significant lack of research into virulence 
mechanisms employed by M. ulcerans beyond the toxin mycolactone, compared to other 
aspects of the disease. Non-toxigenic members of the Mycobacterium genus have caused 
infections for thousands of years, resulting in significant morbidity and mortality. Many of the 
virulence mechanisms used by other species of mycobacteria have analogous genetic loci in M. 
ulcerans (22), although a characterization of the presence and role of these mechanisms is 
severely overshadowed by research into the effects of mycolactone. There is little doubt that 
mycolactone can cause dramatic cytopathology, measured in both in vitro cell culture models 
and model infections in animals. However, the presence of and specific role of mycolactone 
during clinical infection with different ecovars of the bacilli is severely lacking.  
Since the investigation of mycolactone has monopolized research over many years, 
isolates commonly used during experimental infections produce a significant amount of the 
toxin. These isolates may have been selected due to their mycolactone-associated virulence, in 
an effort to analyze its effects. This has led to many important discoveries regarding the 
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mechanisms of the toxin. However, an important distinction between clinical isolates and 
commonly used experimental isolates may exist, in that strains over expressing mycolactone 
may be supra-virulent compared to isolates of an environmental origin commonly infecting 
people. More specifically, that the over-expressing strains commonly evaluated in model 
infections do not accurately represent the phenotype of M. ulcerans in endemic areas. 
Experiments presented in this dissertation, in concert with a few studies investigating infection 
by mycolactone-negative mutants, have documented severe pathogenesis as a result of 
infection (Chapter 3). Mycolactone was also not required for colonization of A. gambiae 
mosquitos (Chapter 4) and other species of insects (52), indicating the presence of mechanisms 
for persistence in environmental and aquatic niches irrespective of the toxin. This dissertation 
has initiated the study of uncharacterized virulence factors that influence pathogenesis.  Until 
more stringent efforts are made to characterize the presence of the toxin during natural 
infection, an evaluation of additional virulence determinants of M. ulcerans will be critical to 
the understanding of this pathogen during its lifecycle.  
A common feature during infection with M. tuberculosis, M. marinum, and M. leprae is a 
disruption of host-lipid metabolism (219, 243, 244). Analogous mechanisms were proposed in 
Chapter 5 regarding disruption of lipid metabolism of mosquitoes exposed to M. ulcerans 
bacilli. The lack of research into other virulence mechanisms encoded by M. ulcerans is severely 
hampering a thorough understanding of this pathogen. Interestingly, Corynebacterium ulcerans 
and C. pseudotuberculosis bacteria, phylogenetic relatives of the Mycobacterium genus, secrete 
phospholipase D as an exotoxin involved with virulence (245).  The most recent study describing 
the synthesis and secretion of phospholipase C and D in M. ulcerans (116), was published nearly 
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15 years ago. This finding is significant for many reasons. The activity of the phospholipase C 
(Plc) enzyme results in the cleavage of phosphatidylcholine (PC) into diacylglycerol (DAG) which 
can then activate protein kinase C, causing malfunction of phagocytes (116, 117) (Figure 17). 
Secretion of Plc by other bacterial pathogens has been shown to disrupt tissue epithelium and 
increase sub-epithelial tissue destruction via matrix metalloproteinase production (246). 
Disruption of phagocytes and subepithelial cell destruction has initially been attributed to 
mycolactone (247), with very little analysis of the activities of M. ulcerans encoded Plc working 
concurrently. Additionally, the activity of M. ulcerans encoded phospholipase D (Pld) results in 
the cleavage of PC producing phosphatidic acid (PA). PA has been shown to promote 
colonization of tissues and apoptosis during infection with C. paratuberculosis and may have 
analogous mechanisms during M. ulcerans infection (248). No additional studies have 
investigated the role of this potent, and relatively common, virulence mechanism during 
infection with M. ulcerans.   
Biochemical analyses of host-pathogen interactions are becoming increasingly common, 
as the application of more sensitive and complex tools such as mass spectrometry become 
more user-friendly. The group of omics technologies are powerful tools for the analysis of these 
interactions. The use of unbiased, global analysis of biological conditions is useful for the 
discovery of biomarkers and descriptive studies, although a holistic approach is necessary for 
complete understanding. The use of omics tools can provide a significant amount of data, but 
reductionist use of these tools limit their application to the understanding of component parts 
of an interaction. LC-MS based metabolomic studies are inherently more holistic than the other 
omics applications, due to their analysis on a comparatively larger scale, especially in the case 
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of host-pathogen interactions.  Metabolism is an intrinsically dynamic process, complete with 
temporal and spatial effects. A single analysis of the metabolome of a given interaction will only 
capture a small snapshot of the metabolites present. To further enhance the biological 
significance of the data collected, and to get a complete picture of the interaction, repeated 
measures must be analyzed.  The application of metabolomics in Chapter 5 is an initiation of a 
study to better understand the virulence mechanisms promoting survival of M. ulcerans in 
mosquitoes. From this study we were able to gain insight into potential virulence mechanisms 
employed by the pathogen which subsequently affect the development of the mosquito. Taken 
together, the data provided here represent a systems biology approach to understanding the 
biology of M. ulcerans in many environments.   
Future Directions 
The sheer number of unknowns still associated with infection with M. ulcerans leaves 
much room for expanded studies. Since a shared association of environmental locations 
between mosquitoes and M. ulcerans is well established, continued studies investigating the 
role of mosquitoes in transmission is critical. Unfortunately, many aspects of this investigation 
are exceedingly difficult. From an epidemiological viewpoint, many factors influence the 
probability that mosquitoes will actively transmit an infection. These factors have been 
mathematically modeled and are used to predict aspects of transmission in other mosquito-
borne diseases (249). An analysis of these factors as they related to Buruli Ulcer disease would 
significantly enhance our understanding of the vectorial capacity of mosquitoes to transmit M. 
ulcerans. The probability that a mosquito becomes infected during its lifetime is unknown, 
although high rates of M. ulcerans DNA contamination of mosquitoes in endemic areas suggests 
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high rates of exposure or at least contact. The next measure would be the mosquito feeding 
rate, or the proportion of mosquitoes that have fed on a human. If the probability that 
mosquitoes can become infected is high, the rate they feed on humans will influence the 
likelihood that the bacteria can be transmitted. As an example, if mosquitoes truly vector the 
pathogen, mosquito bites should account for roughly 99% of the reported 7000 cases per year. 
Estimates of the biting rate of A. gambiae are subject to seasonal rainfall amounts and 
proximity to larval habitats, among other factors, although the biting rate of infected versus 
uninfected mosquitoes is another variable to consider. Considering the high density of 
Anopheles mosquitoes in endemic regions, and the number of mosquito bites received by a 
susceptible individual, the rate of infected mosquitoes biting people and successfully 
transmitting the pathogen would be very low. Based on our mosquito studies (Chapters 4,5), 
the developmental defects associated with exposure to M. ulcerans would further reduce the 
likelihood that a contaminated mosquito would transmit the infections. However, in a pilot 
study we determined that Culex sp. mosquitoes do not suffer any developmental delay or 
reduced fitness upon exposure to the bacilli. We did not measure the external contamination 
rate of the mosquitoes, although stronger, more aggressive mosquitoes may be more likely to 
transmit the bacilli. It may be that mosquitoes other than Anopheles sp. (or Anopheles species 
other than A. gambiae) may be better equipped to handle exposure to the pathogen.   
A more thorough characterization of clinical isolates for mycolactone expression and 
other virulence factors would dramatically enhance our understanding of M. ulcerans biology. 
Our studies have revealed mechanisms of disruption of host-lipid metabolism in the absence of 
mycolactone. These findings represent a solid foundation for the investigation of other 
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virulence factors that contribute to pathogenesis. A metabolomic study of model infection or 
clinical infection has not been performed and would contribute a vast amount of information 
regarding host metabolic disruptions upon infection. This avenue of research is attractive, as 
metabolic analyses in mammal systems would be easier to perform compared to insect 
systems. Libraries of metabolic molecules are better characterized in mammal systems, thus an 
investigation of this nature may provide more biological significance than our investigation of 
the mosquito model.  Infection by a selection of strains with diverse phenotypes could be 
modeled in mice. Subsequently, an analysis of host metabolism over the course of infection 
could be compared to gross pathogenesis and histological assessment. It is likely that many M. 
ulcerans ecovars would utilize a base set of virulence factors, such as phospholipase C/D, and 
the presence of mycolactone might affect the temporal and spatial characteristics of lesion 
development. Additionally, the metabolomic analysis of mycolactone negative infection in 
mammals would provide a sound basis of evidence for the effects of virulence factors without 
the contribution of mycolactone.  
A major research gap in the analysis of M. ulcerans infection is lack of knowledge 
regarding the actual infective dose or the contribution of dose in the pathogenesis during 
infection. Most infectious disease have a strong relationship between dose and incubation 
period. One of the only studies to investigate the incubation period of Buruli Ulcer disease 
described an average of 135 days in an Australian cohort of patients (79). This finding may 
suggest that due to the exceptionally slow growth of the bacilli coupled with what is likely to be 
a very small dose, they bacteria require a long incubation period in order to achieve a 
population sufficient to produce a clinically symptomatic infection (48).  A dose response study 
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in a model infection of a rodent (Thryonomys swinderianus) found a relationship between dose 
and onset of symptoms (250). The authors found that the high inoculum dose resulted in an 
earlier onset of lesions with more severe presentation compared to the low dose, and 
speculate that the infective dose may account for differences in clinical presentation. However, 
another study using different doses to infect armadillos found no difference in pathology 
between doses, but a reportable difference in pathology within each dose (251). Unfortunately, 
the lowest dose reported used in the armadillo study was 3x105 cells per inoculation, whereas 
the low dose used in the Thryonomys model was 3x108 cells per inoculation. It is extremely 
unlikely that an insect vector would introduce 300 million cells during a bloodmeal.  Thus, new 
studies investigating the pathogenesis of low-dose infections is required if an insect vector is to 
be seriously considered.  Along these lines, the sialome (molecular components of saliva) of 
mosquitoes contains a large number of bioactive molecules including anti-inflammatory and 
immunomodulatory agents, and allergenic compounds (252). These salivary components play a 
crucial role in pathogen transmission and the induction or suppression of host-immune and 
inflammatory responses (253). The injection of M. ulcerans bacilli in the context of 
immunomodulatory components of mosquito saliva is an attractive hypotheses investigating 
vector-borne transmission. Since little is known about the pathogenesis of infection after 
inoculation with fewer than 300,000 cells, a study describing the pathogenesis of infection 
when 10-100 cells are inoculated with purified mosquito salivary extracts could provide 
definitive data regarding the capacity of mosquitoes to transmit the disease, the contribution of 
mosquito saliva in the initiation of infection, and the dose required for development of classical 
infection.    
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The unfortunate position on the bottom of the funding scale compared to other 
neglected tropical disease will continue to influence our understanding of Mycobacterium 
ulcerans. Increased awareness and the dissemination of knowledge are the primary 
countermeasures against the continued emergence of these deadly and disfiguring infections. 
This practice is supported by passionate and dedicated scientists. A holistic approach to 
understanding the mechanisms involved in disease transmission and persistence in the 
environment in concert with better knowledge of factors that influence host susceptibility 
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Appendix figure 8: NIST spectral match and head-to-tail plot for compound C336. 
